Annual Report • Mar 31, 2015
Annual Report
Open in ViewerOpens in native device viewer
Annual Report For the Year Ended 31 March 2015
Maven Income and Growth VCT 6 PLC is a venture capital trust (VCT) and its shares are listed on the Premium segment of the Official List and traded on the main market of the London Stock Exchange. It has one class of share and was incorporated on 2 November 1999.
The Company aims to achieve long term capital appreciation and generate maintainable levels of income for Shareholders.
The Articles of Association require the Directors to put a proposal for the continuation of the Company, in its then form, to Shareholders at the Company's Annual General Meeting to be held in 2020.
Shares in the Company can be purchased and sold in the market through a stockbroker. For qualifying investors buying shares on the open market:
The Stockbroker to the Company is Shore Capital Stockbrokers (020 7647 8132).
The Company currently conducts its affairs so that the shares issued by it can be recommended by authorised financial advisers to ordinary retail investors in accordance with the rules of the Financial Conduct Authority (FCA) in relation to non-mainstream investment products and intends to continue to do so for the foreseeable future. The Company's shares are excluded from the FCA's restrictions which apply to nonmainstream investment products because they are shares in a VCT and the returns to investors are predominantly based on investments in private companies or publicly quoted securities.
Shareholders in a number of UK registered companies have received unsolicited calls from organisations, usually based overseas or using false UK addresses or phone lines routed abroad, offering to buy shares at prices much higher than their current market values or to sell non-tradable, overpriced, high risk or even nonexistent securities. Whilst the callers may sound credible and professional, Shareholders should be aware that their intentions are often fraudulent and high pressure sales techniques may be applied, often involving a request for an indemnity or a payment to be provided in advance.
If you receive such a call, you should exercise caution and, based on advice from the FCA, the following precautions are suggested:
Telephone: 0300 123 2040 Website: www.actionfraud.police.uk FCA
Telephone: 0800 111 6768 (freephone)
E-mail: [email protected]
Website: www.fca.org.uk
Register: www.fca.org.uk/firms/systems-reporting/register Scam warning: www.fca.org.uk/consumers/scams
| Proposed final dividend | ||||
|---|---|---|---|---|
| Rate | 0.70p | |||
| XD date | 13 August 2015 | |||
| Record date | 14 August 2015 | |||
| Dividend investment |
election date 28 August 2015 | |||
| Payment date 11 September 2015 |
Financial Statements
Strategic Report
| 31 March 2015 |
31 March 2014 |
31 March 2013 |
|
|---|---|---|---|
| Net asset value (NAV) | £4,187,000 | £3,617,000 | £2,874,000 |
| NAV per Ordinary Share | 57.9p | 56.5p | 54.1p |
| Dividends paid or proposed for year | 0.7p | 0.6p | 0.5p |
| Dividends paid to date | 1.1p | 0.5p | nil |
| NAV total return per share1 | 59.0p | 57.0p | 54.1p |
| Share price2 | 43.5p | 41.5p | 35.0p |
| Discount to NAV | 24.9% | 26.5% | 35.3% |
| Annual yield3 | 1.6% | 1.4% | 1.4% |
| Ordinary Shares in issue | 7,232,852 | 6,407,688 | 5,309,102 |
1 Sum of NAV per share and dividends paid to date (excluding initial tax relief).
2 Mid-market price (Source: Bloomberg).
3 Based on full year dividend and share price at year end.
The above chart shows the NAV total return per share as at 31 March in each year. Dividends that have been proposed but not yet paid are included in the NAV at the balance sheet date. The policy for valuing investments is disclosed in Note 1 to the Financial Statements.
The above graph depicts the movement in the Company's NAV per share and share price, rebased to 100p, over the period from March 31 2005.
| Year ended 31 March | Payment date | Revenue/capital | Interim/final | Rate (p) |
|---|---|---|---|---|
| 2013 | 30 August 2013 | Revenue | Final | 0.5 |
| 2014 | 29 August 2014 | Capital | Final | 0.6 |
| 2015 | 11 September 2015 | Capital | Proposed final | 0.7 |
| Total dividends paid or proposed | 1.8 |
Your Board The Board of five Directors, all of whom are non-executive and the majority of whom are considered by the Board to be independent of the Manager, supervises the management of Maven Income and Growth VCT 6 PLC and looks after the interests of its Shareholders. The Board is responsible for setting and monitoring the Company's strategy and the biographies set out below indicate the Directors' range of investment, commercial and professional experience. Further details are also provided in the Directors' Report on page 34 and the Statement of Corporate Governance on pages 41 to 45.
Relevant experience and other directorships: Jonathan worked at Phillips and Drew from 1962 to 1967 and at L Messel & Co from 1968 to 1986, specialising in investment trusts. He was manager of the corporate division of Thomson T-Line from 1987 to1989 and was director in charge of the London office of Bell Lawrie White from 1990 to 1993. From 1993 to 1999 Jonathan was a director of S G Warburg Securities (now UBS), specialising in investment trust corporate broking. He is currently chairman of Galaxy Asset Management Limited and is a former chairman of Aberdeen Private Equity Fund Limited.
Length of service: He was appointed as a Director and as Chairman on 22 March 2000.
Last re-elected to the Board: 27 August 2014
Committee membership: Chairman of Audit, Management Engagement, Nomination, Remuneration and Risk.
Employment by the Manager: None
Shared directorships with other Directors: None
Shareholding in Company: 10,000 Ordinary Shares
Stephen Barclay Independent Non-executive Director
Jonathan Carr Chairman and Independent
Non-executive Director
Relevant experience and other directorships: Stephen has spent 30 years as a specialist, both as a principal and as an advisor, in the small and micro-cap investment sector, in which he holds a number of private company directorships, and now heads up his family's investment office. He was formerly executive chairman of Seymour Pierce Limited. Stephen is an emeritus governor at the London School of Economics, having been a member of the Court of Governors for 20 years and a member of the executive committee for six years, and he is a member of the investment committee, which he has chaired for six years. Since 1994 he has been a Fellow of Green Templeton College at University of Oxford, from which he received an honorary masters degree. Stephen has also helped to establish the Oxford Centre for the Study of Philanthropy, where is deputy chairman.
Length of service: He was appointed as a Director on 22 March 2000.
Last re-elected to the Board: 27 August 2014
Committee membership: Audit, Management Engagement, Nomination, Remuneration and Risk.
Employment by the Manager: None
Shared directorships with other Directors: None
Shareholding in Company: 138,434 Ordinary Shares
Gregor Logan Independent Non-executive Director
Relevant experience and other directorships: Gregor is an external member of the investment committee of Family Investments Friendly Society; a member of the investment advisory group to Nutmeg, an award winning on-line discretionary investment manager; honorary investment adviser to the Incorporated Society of Musicians; and a trustee of the Fenton Arts Trust. He is a non-executive director of Skiplex Ltd and a former non-executive director of Sidonis Limited. In his early career, Gregor trained with W&J Burness Solicitors before joining Fidelity Investments as a portfolio manager. He then joined the board of MGM Assurance as investment director, moving on to be chief investment officer at Pavilion Asset Management and then New Star Asset Management.
Length of service: He was appointed as a Director on 10 February 2015.
Last re-elected to the Board: N/A
Committee membership: Audit, Management Engagement, Nomination, Remuneration and Risk.
Employment by the Manager: None
Shared directorships with other Directors: None
Shareholding in Company: 45,450 Ordinary Shares
Brian May Independent Non-executive Director
Relevant experience and other directorships: Brian graduated from Stanford University, California in 1983. From 1984 to 1988 he worked for Aitken Hume Plc as a small companies fund manager for Sentinel Funds Management Limited. Since 1989, he has been managing director of Berthon Boat Company Limited and he is a director of a number of other small companies.
Length of service: He was appointed as a Director on 22 March 2000.
Last re-elected to the Board: 27 August 2014
Committee membership: Audit, Management Engagement, Nomination, Remuneration and Risk.
Employment by the Manager: None
Shared directorships with other Directors: None
Shareholding in Company: 261,977 Ordinary Shares
Bill Nixon Non-executive Director
Relevant experience and other directorships: Bill is managing partner of Maven Capital Partners UK LLP (Maven) and has over 35 years' experience in banking and private equity. He is a Fellow of the Chartered Institute of Bankers in Scotland and obtained a Master of Business Administration degree from Strathclyde University in 1996. In the 1990s Bill was head of the private equity business at Clydesdale Bank plc, a subsidiary of National Australia Bank, before joining Aberdeen Asset Management (Aberdeen) in 1999. In 2004 he was appointed as principal fund manager to all Aberdeen managed VCTs. In 2009 Bill and his senior colleagues led a management buy-out from Aberdeen to form Maven. He is a director of Maven Income and Growth VCT 2 PLC, Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC.
Length of service: He was appointed as a Director on 21 February 2006.
Last re-elected to the Board: 27 August 2014
Committee membership: None
Employment by the Manager: Since 1999 (1999-2009 with Aberdeen)
Shared directorships with other Directors: None
Shareholding in Company: 174,179 Ordinary Shares
On behalf of your Board I am pleased to announce the results for the twelve months to 31 March 2015. This was a year of further steady progress for your Company, with a number of successful exits being achieved which, combined with an increase in NAV to 57.9p, has enabled your Board to propose an increased final dividend of 0.7p.
During the period under review a total of £1.1 million was generated from realisations, including the profitable disposal of the holding in Fotolec Technologies, a business we first supported in 2001 and the largest legacy investment within the portfolio. A secondary buyout of Westway Services Holdings (2010) and full exits from Adler and Allan Holdings and EFC Group were also achieved during the year.
These proceeds have enabled your Company to continue its strategy of steadily building an asset base of later-stage, income producing private companies. Full details of the new investments completed in the year are included in the Investment Manager's Review on pages 18 to 23, which also highlights material developments within existing investee businesses, the majority of which are trading well. Most notably, positive performance by Nenplas Holdings, Steminic, John McGavigan, Westway Services Holdings (2014) and HCS Control Systems Group has resulted in their valuations being increased, although provisions have been taken against the holdings in CHS Engineering Services, DPP and Maven Co-invest Fletcher to reflect trading results.
The Board recommends that a final capital dividend of 0.7p per Ordinary Share be paid on 11 September 2015 to Shareholders on the Register at 14 August 2015, representing a yield of 1.6% based on the year-end mid-market share price of 43.5p and the third successive increase in the level of distribution. The effect of paying the proposed final dividend would be to reduce the NAV of the Company by the total cost of the distribution.
The Directors have agreed to implement a DIS through which Shareholders may elect to have their dividend payments used to apply for additional Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS will qualify for VCT tax reliefs applicable for the tax year in which they are allotted.
9
NAV total return of 59.0p per share (2014: 57.0p) at the year end, up 3.5% over the year
NAV at period end of 57.9p per share (2014: 56.5p)
Eleven new private equity investments added to the portfolio
Realisation of Adler and Allan Holdings for a total return of 2.6 times cost
Sale of Fotolec Technologies, generating cash proceeds of £319,000
Exit from EFC Group, generating a total return multiple of 3.8 times cost
Increased final dividend of 0.7p per share (2014: 0.6p) proposed Full details of the scheme, together with a mandate form, are being made available alongside this Annual Report to enable Shareholders to take advantage of the DIS in respect of the final dividend for the year ending 31 March 2015. Shareholders wishing to do so should ensure that a mandate form, or CREST instruction if appropriate, is submitted by no later than the election date of 28 August 2015. Under current VCT legislation, dividends that are invested will be eligible for income tax relief at 30% of the amount invested, subject to an annual investment limit of £200,000, in aggregate, per individual for all investments into new VCT Shares in a tax year.
In September 2013 the Company announced that it planned to raise up to £1 million in a joint Offer for Subscription alongside offers by the other Maven VCTs. The Offer was fully subscribed and closed on 30 May 2014. Relevant details regarding shares issued during the year under review in respect of the Offer can be found in Note 11 to the Financial Statements.
As the Company had a relatively higher amount of cash available for investment under the VCT 'new money' rules than the other Maven VCTs, the Board elected not to participate in the Maven VCT Offers launched on 20 October 2014.
Shareholders should be aware that the Board's primary objective is for the Company to retain sufficient liquid assets for making investments in line with its stated policy and for the continued payment of dividends to Shareholders. However, the Directors also acknowledge the need to maintain an orderly market in the Company's shares and have delegated authority to the Manager to buy back shares in the market for cancellation or to be held in treasury, subject always to the availability of reserves and such transactions being in the best interests of Shareholders. No shares were bought back during the period under review.
The AIFMD regulates the management of alternative investment funds, including VCTs, and the Board has received approval from the FCA as a self-managed small registered UK AIFM under the AIFMD. A new Risk Committee has been established, and information regarding the composition and responsibilities of this committee can be found in the Report by the Audit and Risk Committees on pages 47 to 50.
The Association of Investment Companies (AIC) participated in a consultation process on 'tax-advantaged venture capital schemes' to assist the Government's discussions with the European Commission regarding a review of the State Aid rules for businesses in member countries. Although the Company is not a member of the AIC, the Board supported the AIC's response, in which a number of recommendations were made that we believe would protect the VCT scheme against the imposition of further restrictions on investment.
The 2015 Budget announced a package of changes to the VCT scheme, including a new age limit on companies qualifying for investment and a new cap on total EIS/VCT investment that a company can receive. As the limits proposed are higher than the provisions intended to be introduced as a result of European Union (EU) requirements, and are subject to State Aid approval, the legislation has not been published in the Finance Bill 2015; a consultation period for comments on the draft legislation closed on 15 May 2015.
On 15 April 2015, HM Revenue & Customs (HMRC) published guidance on how it intends to apply the new proposed rule changes to investments made between 6 April 2015 and the date the EU grants State Aid approval, which involves new procedures in particular circumstances where investments exceed the basic EU limits of seven years and €15 million in total.
This has resulted in a degree of uncertainty as to whether or not specific new investments made after 6 April 2015 will be VCT qualifying, and may restrict the number and range of later-stage small and medium-sized enterprises that are available for your Company to invest in.
The FCA has removed the requirement for listed companies to publish quarterly interim management statements. However, your Company will continue to announce the NAV per share on a quarterly basis.
In the 2014 Annual Report, your Board intimated its intention to implement a succession plan and, as indicated previously, Stephen Barclay will stand down and not seek re-election at the Annual General Meeting (AGM) to be held on 3 September 2015. After an open recruitment process involving discussions with several candidates, Gregor Logan was appointed to the Board with effect from 10 February 2015. Gregor will also serve on the Company's Audit, Management Engagement, Nomination, Remuneration and Risk Committees, and is subject to re-election by Shareholders at the 2015 AGM, being the first following his appointment.
It is also intended that, subject to Shareholders' approval for my re-election at that AGM, I will stand down as Chairman at the subsequent AGM in 2016. The future constitution of the Board will be confirmed and communicated fully to Shareholders in due course, with each new Director being subject to re-election at the first AGM following their appointment.
I would like to take this opportunity to thank Stephen for the valued and significant contribution that he has made to the Board since the inception of your Company and to wish him well for the future.
Shareholders are able to elect to receive postal or e-mail notifications that documents, including Annual and Interim Reports, are available on the Company's website as an alternative to receiving hard copies by post. Letters were provided with the most recent Annual and Interim Reports, which Shareholders could complete to confirm whether or not they wished to take advantage of this facility. In the absence of a letter being returned, a Shareholder will have been deemed as having given their consent to receiving only postal notifications that documents are available on the website. Therefore, Shareholders who have previously made an election for postal notification, and those who elected not to respond, will have received notification by post of the publication of this Annual Report on the Company's website. Shareholders who wish notifications to be sent by e-mail rather than by post should complete and return the form enclosed with this Annual Report, or advise the Registrar via www.capitashareportal.com. Hard copies of all documents are available on request.
Your Board believes that the Manager's strategy of investing in a diversified portfolio of private companies will result in a continued improvement in the level of revenue generated from the portfolio, and deliver further growth in Shareholder value.
Jonathan Carr Chairman 17 July 2015
For the Year Ended 31 March 2015
| Opening value 31 March 2014 £'000 |
Purchases £'000 |
Sales proceeds £'000 |
Realised gain/(loss) over opening value £'000 |
Unrealised gain/ (loss) over opening value £'000 |
Closing value 31 March 2015 £'000 |
Total gain/ (loss) £'000 |
|
|---|---|---|---|---|---|---|---|
| Unlisted | 3,066 | 961 | (1,086) | 228 | 67 | 3,236 | 295 |
| Listed | 15 | - | (8) | 8 | (10) | 5 | (2) |
| AIM/ISDX | 55 | 74 | (13) | (4) | 12 | 124 | 8 |
| UK treasury bills | - | 9 98 | (1,000) | 2 | - | - | 2 |
| Total portfolio | 3,136 | 2,033 | (2,107) | 234 | 69 | 3,365 | 303 |
This Business Report is intended to provide an overview of the strategy and business model of the Company as well as the key measures used by the Directors in overseeing its management. The Company is a venture capital trust which invests in accordance with the investment objective set out below.
The Company aims to achieve long term capital appreciation and generate maintainable levels of income for Shareholders.
Under an investment policy approved by the Directors, the Company intends to achieve its objective by:
The principal risks and uncertainties facing the Company are as follows:
Many of the Company's investments are in small and medium sized unlisted and AIM/ ISDX quoted companies which, by their nature, entail a higher level of risk and lower liquidity than investments in large quoted companies. The Board aims to limit the risk attaching to the investment portfolio as a whole by ensuring that a structured selection, monitoring and realisation process is applied. The Board reviews the investment portfolio with the Manager on a regular basis.
The Company manages and minimises investment risk by:
An explanation of certain risks and how they are managed is contained in Note 16 to the Financial Statements.
As most of the investments require a mid to long term commitment and are relatively illiquid, the Company retains a portion of the portfolio in cash or cash equivalents in order to finance any new unquoted investment opportunities. The Company has no direct exposure to currency risk and does not enter into any derivative transactions.
The valuation of investment companies may be affected by underlying economic conditions such as fluctuating interest rates and the availability of bank finance.
The Company may hold financial instruments and cash deposits and is dependent on counterparties discharging their agreed responsibilities. The Directors consider the creditworthiness of the counterparties to such instruments and seek to ensure that there is no undue concentration of exposure to any one party.
The Board reviews regularly the system of internal controls, both financial and non-financial, operated by the Company and the Manager. These include controls designed to ensure that the Company's assets are safeguarded and that all records are complete and accurate.
The Company operates in a complex regulatory environment and faces a number of related risks, including:
In order to maintain its approval as a VCT, the Company is required to comply with current VCT legislation in the UK as well as the European Commission's (EC) state aid rules. Changes in the future to UK legislation or the EC state aid rules could have an adverse impact on Shareholder investment returns whilst maintaining the Company's VCT status. The Board and the Manager continue to make representations where appropriate, either directly or through relevant industry bodies such as the AIC and the British Venture Capital Association (BVCA).
The Company is adhering to its stated investment policy and managing the risks arising from it. This can be seen in various tables and charts throughout the Annual Report, and from information provided in the Chairman's Statement and the Investment Manager's Review. A review of the Company's business, its position as at 31 March 2015 and its performance during the year then ended is included in the Chairman's Statement, which also includes an overview of the Company's strategy and business model.
The management of the investment portfolio has been delegated to Maven Capital Partners UK LLP (Maven), which also provides company secretarial, administrative and financial management services to the Company. The Board is satisfied with the depth and breadth of the Manager's resources and its network of offices which supply new deals and enable it to monitor the geographically widespread portfolio of companies effectively.
The Investment Portfolio Summary on pages 30 and 31 discloses the investments in the portfolio and the degree of co-investment with other clients of the Manager. The tabular analysis of the unlisted and quoted portfolio on pages 16 and 17 show that the portfolio is diversified across a variety of sectors and deal types. The level of VCT qualifying investment is monitored by the Manager on a daily basis and reported to the Risk Committee quarterly.
At each Board Meeting the Directors consider a number of financial performance measures to assess the Company's success in achieving its objectives, and these also enable Shareholders and investors to gain an understanding of its business. The key performance indicators are as follows:
The NAV total return is a measure of the current NAV per share and dividends paid to date. The dividend growth measure shows how much of that Shareholder value has been returned to original investors in the form of dividends. A historical record of these measures is shown in the Financial Highlights on pages 5 and 6 and the profile of the portfolio is reflected in the Summary of Portfolio Performance on page 12. The Board reviews the Company's investment income and operational expenses on a quarterly basis.
There is no meaningful venture capital trust index against which to compare the financial performance of the Company but, for reporting to the Board and Shareholders, the Manager uses comparisons with appropriate indices and the Company's peer group. The Directors also consider nonfinancial performance measures such as the flow of investment proposals and the Company's ranking within the VCT sector by independent analysts.
Investments held by Maven Income and Growth VCT 6 PLC in unquoted companies are valued in accordance with the International Private Equity and Venture Capital Valuation Guidelines. Investments quoted or traded on a recognised stock exchange are valued at their bid prices.
The Board will seek the necessary Shareholder authority to conduct a share buy-back programme under appropriate circumstances.
The Company has no direct employee or environmental responsibilities, nor is it responsible for the emission of greenhouse gases. However, the Directors will consider economic, regulatory and political trends and features that may impact on the Company's future development and performance. The Board's principal responsibility to Shareholders is to ensure that the investment portfolio is managed and invested properly. The management of the portfolio is undertaken by the Manager through members of its portfolio management team. The Manager engages with the Company's underlying investee companies in relation to their corporate governance practices and in developing their policies on social, community and environmental matters and further information may be found in the Statement of Corporate Governance. In light of the nature of the Company's business, there are no relevant human rights issues and, therefore, the Company does not have a human rights policy.
The Company's Auditor is required to report if there are any material inconsistencies between the content of the Strategic Report and the Financial Statements. The Independent Auditor's Report can be found on pages 51 to 54.
The Board and Manager intend to maintain the policies set out above for the year ending 31 March 2016 as it is believed that these are in the best interests of Shareholders.
Jonathan Carr Chairman 17 July 2015
As at 31 March 2015
| Unlisted valuation |
Quoted valuation |
Total valuation |
||||
|---|---|---|---|---|---|---|
| Industry sector | £'000 | % | £'000 | % | £'000 | % |
| Energy services | 790 | 23.5 | - | - | 790 | 23.5 |
| Support services | 507 | 15.1 | 94 | 2.8 | 601 | 17.9 |
| Insurance | 414 | 12.3 | 5 | 0.1 | 419 | 12.4 |
| Construction & building materials | 260 | 7.7 | - | - | 260 | 7.7 |
| Telecommunication services | 254 | 7.5 | - | - | 254 | 7.5 |
| Software & computer services | 188 | 5.6 | 11 | 0.3 | 199 | 5.9 |
| Automobiles & parts | 191 | 5.7 | - | - | 191 | 5.7 |
| Diversified industrials | 125 | 3.7 | - | - | 125 | 3.7 |
| Electronic & electrical equipment | 124 | 3.7 | - | - | 124 | 3.7 |
| Engineering & machinery | 100 | 3.0 | - | - | 100 | 3.0 |
| Pharmaceuticals & biotechnology | 75 | 2.2 | - | - | 75 | 2.2 |
| General retailers | 72 | 2.1 | - | - | 72 | 2.1 |
| Household goods & textiles | 50 | 1.5 | 10 | 0.3 | 60 | 1.8 |
| Chemicals | 60 | 1.8 | - | - | 60 | 1.8 |
| Real estate | 26 | 0.8 | - | - | 26 | 0.8 |
| Media & entertainment | - | - | 9 | 0.3 | 9 | 0.3 |
| 3,236 | 96.2 | 129 | 3.8 | 3,365 | 100.0 |
| Deal type | Number of holdings |
Valuation £'000 |
% |
|---|---|---|---|
| Unlisted | |||
| Management buy-out | 15 | 1,000 | 29.7 |
| Replacement capital | 5 | 564 | 16.8 |
| Development capital | 7 | 487 | 14.5 |
| Buy & build | 3 | 450 | 13.4 |
| Buy-in/management buy-out | 3 | 300 | 8.9 |
| Acquisition finance | 8 | 278 | 8.3 |
| Refinancing | 1 | 99 | 2.9 |
| Management buy-in | 1 | 58 | 1.7 |
| Mezzanine | 1 | - | - |
| Total unlisted | 44 | 3,236 | 96.2 |
| Quoted | 10 | 129 | 3.8 |
| Total unlisted and quoted | 54 | 3,365 | 100.0 |
Bill Nixon Managing Partner Maven Capital Partners UK LLP
The year to 31 March 2015 has been a satisfactory one in terms of accomplishing your Company's investment objective. A number of successful exits were achieved, providing liquidity to continue to expand the portfolio, with new investments structured to provide maximum income and capital gain potential. Delivery of this strategy has resulted in a further increase in NAV and tax-free income for Shareholders.
This has been a good year for your Company, with meaningful realisations for value combined with the addition of a number of defensively structured new private company holdings across a range of industries. The Maven team continues to apply strict criteria to the selection of new portfolio assets, investing only in established and well managed businesses, each available on a reasonable entry multiple and where the investment has a significant income-producing loan stock element. Our experience suggests that this is the optimum strategy to deliver attractive Shareholder returns and maintain a progressive dividend programme.
As the portfolio has continued to mature, the Maven investment team has demonstrated an ongoing ability to create and realise value in investee companies by working closely with management teams to develop exit strategies, and it is pleasing to note that considerable interest has been shown in your Company's assets by both trade and private equity buyers based within the UK and overseas.
Several profitable realisations were achieved, most notably the full exits from Fotolec Technologies, Adler and Allan Holdings and EFC Group as well as the secondary buyout of Westway Services Holdings (2010), which has achieved rapid growth since Maven supported the initial management buy-out in 2009. Satisfactory disposals were made from Tuscola (FC100), Camwatch and Moriond, with insurance proceeds also received in respect of the fire that occurred in 2012 at the Lawrence Recycling and Waste Management plant. The cash generated from these transactions has enabled several new assets to be added to the portfolio during the year across a wide range of UK industries and a broad geographical base.
The investee company portfolio includes a number of businesses which are active in the UK and international oil & gas industry and it is worth making some comment around prospects for the sector given the fall in oil prices. Maven's presence in that global market has been focused on the operational expenditure segment of the industry, rather than being dependent on large capital expenditure programmes or exploration projects. We have invested in businesses that are active in key support services and, in the main, benefit from contracts based on essential maintenance requirements, asset integrity and mandatory health & safety obligations. We believe, therefore, that your Company's investments are relatively well shielded from the challenges facing that sector.
Turning to new investment activity, Maven supported the buy-in/management buy-out of RMEC Group in April 2014 and, shortly thereafter, led a secondary buy-out of Just Trays from Gresham Private Equity. Further investments were completed in Crawford Scientific Holdings, in August 2014, and in specialist cycling apparel business Endura in a transaction led by Penta Capital in October 2014.
In December 2014 Maven led the management buy-out of Fathom Systems Group, a new investment was completed in electronics business CB Technology Group and, in February 2015, your Company participated in the AIM IPO of Angle. Just prior to the period end Flow UK Holdings was added to the portfolio and a development capital funding package was provided to Traceall Global. Maven has also established three new companies to seek out acquisitions in sectors where there are believed to be opportunities and the investment team has relevant industry knowledge and experience.
The private equity portfolio has generally performed well during the year, and strong trading results have led to valuation uplifts for a number of companies operating in a range of sectors. Nenplas Holdings has continued to perform ahead of plan due to operational efficiencies achieved following the integration of Polyplas, increased sales volumes and favourable market conditions. This has led to an uplift in the valuation, and the company has now added to its product range and manufacturing capacity through the acquisition of Wolverhampton based Delta Plastics.
HCS Control Systems Group, which specialises in the design, manufacture and testing of equipment for the global subsea industry, has a strategy to grow through expansion into key markets and has achieved a number of milestones since the investment by Maven clients in June 2013. Trading results have exceeded expectations and the business has won several new contracts, including a valuable project to provide services for the BP Quad 204 development off the coast of Shetland.
It has been an excellent year for John McGavigan, a manufacturer and supplier of technical plastic components and interior parts for the global automotive industry. The UK and Chinese plants have each been successful in securing significant levels of new business and a number of programme launches have been announced, including projects for BMW, Nissan, Volvo, Fiat, Ford and Jaguar Land Rover.
Glacier Energy Services Group provides bespoke solutions to the global energy sector through its operating hubs in the UK, Singapore, United Arab Emirates and Australia. During the reporting period a follow-on investment was made to fund the acquisition of Professional Testing Services, a business that provides a comprehensive range of non-destructive testing services. Glacier subsequently completed its sixth Maven-backed acquisition with the purchase of MSL Heat Transfer, a radiator and cooler provider, and announced a new divisional structure to support its expansion across the Middle East and Australia.
Six Degrees Group was established in 2011 to implement a buy & build strategy in the telecommunications and IT sector and has since completed thirteen acquisitions. The company is now a broadly based business centred on the convergence of mobile, fixed-line, broadband, internet and IT technology businesses, and delivered annual sales of £68.9 million for the year ended 31 March 2014.
Steminic, a supplier of industrial cleaning services, trading as MSIS, has grown into a major provider of cleaning, coating and inspection services since Maven clients first invested in 2007. The company has recently recorded its most successful year, with earnings increasing on the back of investment in new plant and equipment. Subsequent to the year-end, MSIS was sold to London based Primary Capital for £19.5 million.
Torridon (Gibraltar), trading through its subsidiary Elite Insurance, offers specialist insurance solutions and exceptional service across a full range of general insurance classes. Its experienced in-house underwriting teams have continued to expand the product range, delivering bespoke proposals supported by a full risk assessment and effective decision-making, establishing Elite as a market leading provider of legal expenses insurance. Elite now offers over eighty lines across Europe, including before-the-event, afterthe-event and clinical negligence products.
Funding was provided during the year to support a secondary buy-out of existing portfolio company Westway Services Holdings (2010), a provider of technical facility services. The business enjoys a long-standing relationship with M&S, and has a proven track record of delivering a reliable and high quality service to its clients across a broad range of planned and reactive maintenance projects.
In light of trading performance, your Board has taken the prudent step of reducing the valuations in respect of CHS Engineering Services, DPP and Maven Co-invest Fletcher.
During the year under review, alongside follow-on investments supporting the development of existing portfolio companies, your Company invested in three businesses incorporated by Maven in the industrials, engineering and insurance sectors. Additionally, eight new private equity assets were added to the portfolio:
Endura, the largest specialist UK designer and manufacturer of branded apparel for the key cycling categories of mountain, road, performance and leisure, with products sold in over 30 countries. This transaction was led by Penta Capital, an established private equity firm with which Maven previously co-invested in esure, Six Degrees Group and Global Risk Partners;
Fathom Systems Group, a business that provides an extensive range of high-quality engineered products for a global blue chip client base. The diving control systems which Fathom develops are critical to subsea processes and, due to their high safety standards and reliability, are used widely across the diving industry;
One AIM listed investment was added to the portfolio when your Company participated in the IPO of Angle, a med-tech company specialising in cancer research technology. The net proceeds of the placing will be used primarily to support an ovarian cancer clinical study for Angle's patent protected Parsortix system and develop sales for research use to support drug trials.
The following investments have been completed during the period:
| Investment | ||||
|---|---|---|---|---|
| Date | Sector | cost £'000 |
Website | |
| Unlisted | ||||
| Assecurare Limited | December 2014 | Insurance | 50 | No website available |
| Braelaw Limited | December 2014 | Diversified industrials |
50 | No website available |
| Broadwave Engineering Limited | December 2014 | Engineering & machinery |
50 | No website available |
| Caledon Telfer House Limited | April 2014 | Real estate | 50 | No website available |
| CB Technology Group Limited | December 2014 | Electronic & electrical equipment |
58 | www.cbtechnology.co.uk |
| CHS Engineering Services Limited | August 2014 | Support services | 14 | www.chsservices.com |
| Crawford Scientific Holdings Limited |
August 2014 | Pharmaceuticals & biotechnology |
75 | www.crawfordscientific.com |
| D Mack Limited | June 2014 | Automobiles & parts |
7 | www.dmacktyres.com |
| Endura Limited | October 2014 | General retailers | 100 | www.endurasport.com |
| Fathom Systems Group Limited | December 2014 | Energy services | 75 | www.fathomsystems.co.uk |
| Flow UK Holdings Limited | March 2015 | Software & computer services |
75 | www.flow-communications.co.uk |
| JT Holdings (UK) Limited (trading as Just Trays) |
June 2014 | Household goods & textiles |
50 | www.just-trays.co.uk |
| Kelvinlea Limited | June 2014 | Real estate | 11 | No website available |
| Maven Co-invest Endeavour Limited Partnership (invested in Global Risk Partners) |
December 2014 | Insurance | 6 | No website available |
| RMEC Group Limited | April 2014 | Energy services | 50 | www.rmecltd.co.uk |
| Steminic Limited (trading as MSIS) November 2014 | Energy services | 74 | www.msisgroup.com | |
| Traceall Global Limited | March 2015 | Software & computer services |
98 | www.traceallglobal.com |
| Westway Services Holdings (2014) Limited |
November 2014 | Support services | 68 | www.westwayservices.com |
| Total unlisted investment | 961 | |||
| Quoted | ||||
| Angle PLC | February 2015 | Support services | 74 | www.angleplc.com |
| Total quoted investment | 74 | |||
| UK treasury bills | ||||
| Treasury Bill 16 March 2015 | September 2014 | UK government | 998 | |
| Total UK treasury bills | 998 | |||
| Total investment | 2,033 |
Your Company has co-invested in some or all of the above transactions with Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5. At the period end, the portfolio stood at 54 unlisted and quoted investments at a total cost of £3.0 million, and now includes 44 later-stage private company assets.
In August 2014, the legacy holding in Fotolec Technologies was sold at above carrying value, and a profitable realisation was achieved in September 2014 when environmental services business Adler and Allan Holdings was acquired by UK private equity house LDC for a 2.6 times total return over the holding period. Maven clients first invested in Adler and Allan in 2007, alongside Spirit Capital Partners, to support the company's development and have since backed a series of acquisitions to help the group gain scale and grow shareholder value.
In November 2014 Maven realised the investment in control systems specialist EFC Group, via a secondary buy-out to a consortium of investors led by Arle Capital and Front Row Energy Partners, achieving a 3.8 times total return on cost. Since our initial investment in 2009, EFC has more than doubled its turnover and increased employee numbers from 50 to 150 by targeting new international markets, extending the product offering and growing its customer base. Also in November, Camwatch was sold at close to carrying value to VPS Holdings, a leader in the European vacant property services market.
As at the date of this report, the Manager is engaged with several investee companies and prospective acquirers at various stages of a potential exit process. This realisation activity reflects the increasing maturity of a number of holdings, but it should be noted that there can be no certainty that these discussions will lead to profitable sales.
The table below gives details of all realisations, including deferred considerations recevied, during the reporting period:
| Year first invested |
Complete/ partial exit |
Cost of shares disposed of £'000 |
Value at 31 March 2014 £'000 |
Sales proceeds £'000 |
Realised gain/ (loss) £'000 |
Gain/ (loss) over 31 March 2014 value £'000 |
|
|---|---|---|---|---|---|---|---|
| Unlisted | |||||||
| Adler and Allan Holdings Limited | 2007 | Complete | 62 | 87 | 130 | 68 | 43 |
| ATR Holdings Limited | 2007 | Complete | - | - | 1 | 1 | 1 |
| Attraction World Holdings Limited | 2010 | Partial | 4 | 4 | 7 | 3 | 3 |
| Caledon Telfer House Limited1 | 2014 | Complete | 50 | N/A | 50 | - | N/A |
| Camwatch Limited | 2007 | Complete | 182 | 115 | 101 | (81) | (14) |
| Endura Limited1 | 2014 | Partial | 43 | N/A | 43 | - | N/A |
| Enpure Holdings Limited | 2006 | Complete | - | - | 6 | 6 | 6 |
| Ensco 969 Limited (trading as DPP) | 2013 | Partial | 6 | 6 | 6 | - | - |
| Fotolec Technologies Limited | 2001 | Complete | 250 | 285 | 319 | 69 | 34 |
| Intercede (Scotland) 1 Limited (trading as EFC Group)2 |
2009 | Complete | 50 | 147 | 143 | 93 | (4) |
| Kelvinlea Limited | 2013 | Partial | 21 | 21 | 21 | - | - |
| Lawrence Recycling and Waste Management Limited |
2009 | Partial | 8 | 8 | 8 | - | - |
| Manor Retailing Limited | 2013 | Partial | 35 | 35 | 35 | - | - |
| Moriond Limited | 2011 | Complete | 4 | 8 | 10 | 6 | 2 |
| Search Commerce Limited | 2013 | Partial | 35 | 35 | 35 | - | - |
| Space Student Living Limited | 2011 | Partial | 46 | 46 | 46 | - | - |
| Tuscola (FC100) Limited (previously Grangeford (FC100) Limited) |
2012 | Complete | 50 | 50 | 50 | - | - |
| Westway Services Holdings (2010) Limited |
2009 | Complete | 12 | 67 | 75 | 63 | 8 |
| Total unlisted disposals | 858 | 914 | 1,086 | 228 | 79 |
| Year first invested |
Complete/ partial exit |
Cost of shares disposed of £'000 |
Value at 31 March 2014 £'000 |
Sales proceeds £'000 |
Realised gain/ (loss) £'000 |
Gain/ (loss) over 31 March 2014 value £'000 |
|
|---|---|---|---|---|---|---|---|
| Quoted | |||||||
| Brookwell Limited | 2011 | Partial | - | - | 5 | 5 | 5 |
| esure Group PLC | 2010 | Partial | - | 8 | 8 | 8 | - |
| Hasgrove PLC | 2006 | Partial | 17 | 6 | 8 | (9) | 2 |
| Total quoted disposals | 17 | 14 | 21 | 4 | 7 | ||
| UK treasury bills | |||||||
| Treasury Bill 16 March 2015 | 2014 | Complete | 998 | 997 | 1,000 | 2 | 3 |
| Total disposals | 1,873 | 1,925 | 2,107 | 234 | 89 |
1 Holding acquired and realised during the period.
2 Proceeds exclude yield and redemption premiums received, which are disclosed as revenue for financial reporting purposes.
The table includes the redemption of loan notes by a number of investee companies.
Since 31 May 2015 one new private company asset has been added to the portfolio. In June 2015 an investment was completed in Cursor Controls, a manufacturer of trackball pointing solutions which are utilised in a number of industrial applications. Based in Newark, Cursor is widely recognised as a global market leader, with over 1,200 trackball variants in its product portfolio.
In June 2015 funds affiliated with Boston-based private equity firm Charlesbank Capital Partners entered into an agreement to acquire Six Degrees Group and, in the same month, Steminic (trading as MSIS) was sold to UK private equity house Primary Capital, achieving a 3.3 times total return on cost over the life of the investment. Maven clients first invested in Steminic in 2007 and provided additional funding in subsequent years to facilitate growth, enabling the business to more than double its revenues and increase profitability three fold since the original investment.
We believe that the UK economic outlook is generally positive for established private companies and will continue to present attractive investment opportunities which Maven's nationwide team is well placed to source, execute and manage through to a successful exit. We are confident that the proven strategy of investing principally in mature businesses, which are each capable of generating a high level of income and offer the potential to achieve capital appreciation on realisation, will continue to optimise total Shareholder returns.
Maven Capital Partners UK LLP Manager
17 July 2015
As at 31 March 2015
| Cost (£'000) | 21 | |
|---|---|---|
| Valuation (£'000) | 347 | |
| Basis of valuation | Earnings | |
| Equity held | 0.8% | |
| Income received (£'000) | 42 | |
| First invested | Jan 2010 | |
| Year ended | 31 March2 | |
| 2014 | 2013 | |
| £'000 | £'000 | |
| Sales | 125,578 | 112,028 |
| EBITDA1 | 7,863 | 11,325 |
| Net assets | 33,542 | 27,215 |
Torridon was established to acquire Elite, a national supplier of financial and legal insurance products and litigation services in a public-to-private transaction in 2010. Elite provides a range of over eighty lines, including before-theevent, after-the-event and clinical negligence products, as well as medico legal reports and psychological reports to a client base of principally UK based solicitors.
Steminic Limited (trading as MSIS) Aberdeen www.msisgroup.com
| Cost (£'000) | 164 | |
|---|---|---|
| Valuation (£'000) | 287 | |
| Basis of valuation | Earnings | |
| Equity held | 1.2% | |
| Income received (£'000) | 61 | |
| First invested | April 2007 | |
| Year ended | 31 Dec | |
| 2013 | 2012 | |
| £'000 | £'000 | |
| Sales | 12,537 | 9,405 |
| EBITDA1 | 2,161 | 1,085 |
| Net assets/(liabilities) | 115 | (307) |
Steminic is an environmental services group primarily focused on the energy services sector, and acquired MSIS, a provider of industrial cleaning and waste management services in the North East of Scotland, in 2007. Historically, MSIS provided industrial cleaning services to a wide range of clients, and has been successful in expanding its business into the offshore markets, particularly in offering tank cleaning, waste removal and disposal services.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3 and Maven Income and Growth VCT 4
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
| Cost (£'000) | 122 |
|---|---|
| Valuation (£'000) | 260 |
| Basis of valuation | Earnings |
| Equity held | 1.0% |
| Income received (£'000) | 10 |
| First invested | March 2013 |
| Year ended | 31 May3 |
| 2014 | |
| £'000 | |
| Sales | 15,845 |
| EBITDA1 | 3,226 |
| Net assets | 2,781 |
Nenplas is one of the country's leading producers of specialist plastic products. The business designs and manufactures polymer based extrusions for a wide variety of uses including building, shop fitting, caravan and leisure and automotive applications. The business was established as an independent concern following a demerger of Homelux Nenplas, with the technical manufacturing capability retained within Nenplas. The company's strategy is to expand its manufacturing and customer base through selected bolt-on acquisitions.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3 and Maven Income and Growth VCT 4
Maven Co-invest Exodus Limited Partnership (invested in Six Degrees Group) London www.6dg.co.uk
| Cost (£'000) | 87 | |
|---|---|---|
| Valuation (£'000) | 194 | |
| Basis of valuation | Earnings | |
| Equity held | 0.4% | |
| Income received (£'000) | 8 | |
| First invested | June 2011 | |
| Year ended | 31 March | |
| 2014 | 2013 | |
| £'000 | £'000 | |
| Sales | 68,927 | 51,507 |
| EBITDA1 | 11,160 | 7,993 |
| Net assets | 87,624 | 87,983 |
Six Degrees Group was established in 2011 with a buy & build acquisition strategy for the telecommunications and IT sectors, and has since completed thirteen acquisitions. The business is targeting three key managed data services elements: data centre and hosting, network connectivity and cloud offerings. The aim is to help UK mid-market companies meet the challenges of a connected, always-on world. Six Degrees acts as a reseller of converged business communications services to customers where there is a requirement for a 'one stop shop' operation that is beyond most independent voice and data resellers.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
Glacier Energy Services Holdings Limited Aberdeen www.glacier.co.uk
| Cost (£'000) | 150 | |
|---|---|---|
| Valuation (£'000) | 182 | |
| Basis of valuation | Earnings | |
| Equity held | 0.6% | |
| Income received (£'000) | 24 | |
| First invested | March 2011 | |
| Year ended | 31 March | |
| 2014 | 2013 | |
| £'000 | £'000 | |
| Sales | 14,708 | 9,695 |
| EBITDA1 | 2,193 | 1,831 |
| Net assets | 1,155 | 935 |
Glacier was formed in 2011 following the management buyout of Wellclad and Roberts Pipeline Machining from MB Aerospace. The group provides specialist services for energy infrastructure: on-site machining; well overlay for pressure control equipment; non-destructive testing; and heat transfer equipment repair and refurbishment. Glacier has a strong international presence in key energy markets, including the North Sea, the Middle East and West Africa, and focuses on developing products in the areas of production and processing equipment, intervention and pipeline components.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
Lemac No. 1 Limited (trading as John McGavigan) Glasgow www.mcgavigan.com
| Cost (£'000) | 107 | |
|---|---|---|
| Valuation (£'000) | 152 | |
| Basis of valuation | Earnings | |
| Equity held | 1.4% | |
| Income received (£'000) | 27 | |
| First invested | Dec 2010 | |
| Year ended | 31 Dec | |
| 2014 | 2013 | |
| £'000 | £'000 | |
| Sales | 14,602 | 10,557 |
| EBITDA1 | 1,941 | 1,000 |
| Net assets | 1,712 | 745 |
John McGavigan is a manufacturer and supplier of decorative assemblies and interior parts for the global automotive industry, with a strong share of the European market. The business supplies tier 1 manufacturers such as Bosch, Visteon, Continental and Yazaki, with components widely used by global brand car makers producing affordable high volume cars, including Ford, GM, Jaguar Land Rover and Toyota. The principal focus of operations is the design, manufacture and supply of parts, and it also provides a logistics management service, enabling just-in-time supply to manufacturing facilities across the world.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3 and Maven Income and Growth VCT 4
Westway Services Holdings (2014) Limited Ruislip www.westwayservices.com
| Cost (£'000) | 68 | |
|---|---|---|
| Valuation (£'000) | 99 | |
| Basis of valuation | Earnings | |
| Equity held | 0.9% | |
| Income received (£'000) | 2 | |
| First invested | June 2009 | |
| Year ended | 28 Feb | |
| 2014 | 2013 | |
| £'000 | £'000 | |
| Sales | 30,018 | 22,273 |
| EBITDA1 | 4,501 | 2,682 |
| Net assets | 13,845 | 10,563 |
Westway provides design, installation and maintenance services to the built environment. The company's original focus was on heating, ventilation and air-conditioning services but it has expanded its focus to other technical services including M&E maintenance, energy services, communications, internet protocol television and security systems. Westway now provides a full range of building services through a network of residential engineers and mobile technicians.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
Traceall Global Limited Glasgow www.traceallglobal.com
| Cost (£'000) | 98 |
|---|---|
| Valuation (£'000) | 98 |
| Basis of valuation | Cost |
| Equity held | 2.9% |
| Income received (£'000) | Nil |
| First invested | March 2015 |
This company has not yet produced its first report and accounts.
The Company provides remote sensor monitoring and unique asset verification solutions for the global food and beverage industry. Its products and technology are installed into or alongside assets and capture real time data on variables such as location, temperature, product quality, and equipment performance. Clients benefit from total control and visibility over their assets as they move through the supply chain, capturing key sales, quality and engineering data that can be used to make better decisions and protect the brand.
Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
27
| Cost (£'000) | 60 | |
|---|---|---|
| Valuation (£'000) | 95 | |
| Basis of valuation | Earnings | |
| Equity held | 0.6% | |
| Income received (£'000) | 16 | |
| First invested | March 2012 | |
| Year ended | 31 Dec | |
| 2013 | 2012 | |
| £'000 | £'000 | |
| Sales | 5,196 | 7,168 |
| EBITDA1 | (247) | 1,273 |
| Net assets | 215 | 1,558 |
CatTech provides niche industrial services to oil refineries and petrochemical plants across the major international markets, and operates from offices in the UK, Bulgaria, Sweden, China, Singapore and Thailand. The business has developed a range of proprietary products for servicing essential equipment and improving catalyst handling operations. CatTech operates in a sector where the ability to maintain operational efficiency is critical and there is an increasing focus on health and safety issues, and only a limited number of specialist operators world-wide that have the skilled personnel and equipment to undertake catalyst handling projects.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
(trading as XPD8 Solutions Limited) Aberdeen www.xpd8solutions.com
| Cost (£'000) | 79 | |
|---|---|---|
| Valuation (£'000) | 79 | |
| Basis of valuation | Earnings | |
| Equity held | 1.2% | |
| Income received (£'000) | 23 | |
| First invested | June 2010 | |
| Year ended | 31 Dec | |
| 2014 | 2013 | |
| £'000 | £'000 | |
| Sales | 5,497 | 4,695 |
| EBITDA1 | 523 | 337 |
| Net assets | (2,292) | (1,727) |
XPD8 was formed in 2003 and operates in the energy services industry. Asset integrity is an area of increasing focus for the sector, as businesses seek to maximise production and control costs whilst maintaining safety with an ageing infrastructure of critical equipment. XPD8 offers customers an integrated package of bespoke software tools and skilled engineers, which dovetails with customers' own asset integrity processes to help extend the life of critical equipment.
Maven Income and Growth VCT, Maven Income and Growth VCT 2, Maven Income and Growth VCT 3, Maven Income and Growth VCT 4 and Maven Income and Growth VCT 5
Maven offices
Ten largest investments
As at 31 March 2015
| Investment | Valuation £'000 |
Cost £'000 |
% of net assets |
% of equity held |
% of equity held by other clients1 |
|---|---|---|---|---|---|
| Unlisted | |||||
| Torridon (Gibraltar) Limited (formerly Torridon Capital Limited) |
347 | 21 | 8.3 | 0.8 | 39.2 |
| Steminic Limited (trading as MSIS) | 287 | 164 | 6.9 | 1.2 | 50.4 |
| Nenplas Holdings Limited | 260 | 122 | 6.2 | 1.0 | 31.5 |
| Maven Co-invest Exodus Limited Partnership and Tosca Penta Exodus Mezzanine Limited Partnership (invested in Six Degrees Group) |
194 | 87 | 4.6 | 0.4 | 10.3 |
| Glacier Energy Services Holdings Limited | 182 | 150 | 4.3 | 0.6 | 27.1 |
| Lemac No.1 Limited (trading as John McGavigan) | 152 | 107 | 3.6 | 1.4 | 35.4 |
| Westway Services Holdings (2014) Limited | 99 | 68 | 2.4 | 0.9 | 46.3 |
| Traceall Global Limited | 98 | 98 | 2.3 | 2.9 | 12.0 |
| CatTech International Holdings Limited | 95 | 60 | 2.3 | 0.6 | 29.4 |
| Venmar Limited (trading as XPD8 Solutions) | 79 | 79 | 1.9 | 1.2 | 33.8 |
| Ensco 969 Limited (trading as DPP) | 79 | 105 | 1.9 | 0.4 | 34.1 |
| Flow UK Holdings Limited | 75 | 75 | 1.8 | 1.9 | 69.8 |
| Fathom Systems Group Limited | 75 | 75 | 1.8 | 1.0 | 59.0 |
| Crawford Scientific Holdings Limited | 75 | 75 | 1.8 | 0.9 | 47.3 |
| Flexlife Group Limited | 74 | 74 | 1.8 | 0.3 | 14.3 |
| HCS Control Systems Group Limited | 68 | 60 | 1.6 | 0.5 | 36.0 |
| Martel Instruments Holdings Limited | 66 | 76 | 1.6 | 1.4 | 42.8 |
| LCL Hose Limited (trading as Dantec Hose) | 60 | 60 | 1.4 | 1.1 | 28.9 |
| Vodat Communications Group Limited | 60 | 60 | 1.4 | 0.7 | 41.0 |
| CB Technology Group Limited | 58 | 58 | 1.4 | 1.2 | 77.8 |
| Endura Limited | 57 | 57 | 1.4 | 0.2 | 5.7 |
| CHS Engineering Services Limited | 52 | 72 | 1.2 | 0.6 | 22.7 |
| Assecurare Limited | 50 | 50 | 1.2 | 1.0 | 48.8 |
| Braelaw Limited | 50 | 50 | 1.2 | 1.0 | 48.8 |
| Broadwave Engineering Limited | 50 | 50 | 1.2 | 1.0 | 48.8 |
| Richfield Engineering Services Limited | 50 | 50 | 1.2 | 0.8 | 49.0 |
| R&M Engineering Group Limited | 50 | 50 | 1.2 | 0.7 | 69.9 |
| ISN Solutions Group Limited | 50 | 50 | 1.2 | 0.6 | 54.4 |
| JT Holdings (UK) Limited (trading as Just Trays) | 50 | 50 | 1.2 | 0.5 | 29.5 |
Investment Valuation £'000 Cost £'000 % of net assets % of equity held % of equity held by other clients1 Unlisted (continued) SPS (EU) Limited 50 50 1.2 0.5 42.0 RMEC Group Limited 50 50 1.2 0.4 57.9 Attraction World Holdings Limited 42 3 1.0 0.9 37.5 D Mack Limited 39 39 0.9 0.4 29.6 Kelvinlea Limited 27 27 0.6 2.3 47.7 Space Student Living Limited 26 - 0.6 1.7 78.4 Maven Co-invest Endeavour Limited Partnership (invested in Global Risk Partners) 17 17 0.4 0.6 99.4 Manor Retailing Limited 15 15 0.4 0.8 49.0 Search Commerce Limited 15 15 0.4 0.8 49.0 Lawrence Recycling & Waste Management Limited 13 73 0.3 0.8 61.2 Other unlisted investments - 96 - Total unlisted investments 3,236 2,538 77.3 Quoted Angle PLC 89 74 2.2 0.2 0.4 Vianet Group PLC (formerly Brulines Group PLC) 11 16 0.3 - 1.5 Plastics Capital PLC 10 10 0.2 - 1.4 Chime Communications PLC 9 6 0.2 - 0.1 esure Group PLC 5 - 0.1 - - Work Group PLC 4 101 0.1 0.4 2.7 Other quoted investments 1 239 - Total quoted investments 129 446 3.1 Total investments 3,365 2,984 80.4
1 Other clients of Maven Capital Partners UK LLP.
The Directors submit their Annual Report together with the Financial Statements of the Company for the year ended 31 March 2015. A summary of the financial results for the year and the proposed final dividend can be found in the Financial Highlights on pages 5 and 6.
The Company's affairs have been conducted, and will continue to be conducted, in a manner to satisfy the conditions to enable it to continue to obtain approval as a venture capital trust under Section 274 of the Income Tax Act 2007. HMRC will grant Section 274 status, if requested, provided that the Company's affairs have been conducted in such a manner as to satisfy the conditions of that Section of the Act. Such approval was last granted in respect of the year ended 31 March 2014.
The Company's Ordinary Shares are listed on the Premium segment of the Official List and traded on the main market of the London Stock Exchange. Further details are provided in the Corporate Summary.
As a venture capital trust pursuant to Section 274 of the Income Tax Act 2007, the rules of the FCA in relation to non-mainstream investment products do not apply to the Company.
The Company's business activities, together with the factors likely to affect its future development and performance, are set out in this Directors' Report. The financial position of the Company is described in the Chairman's Statement within the Strategic Report. In addition, Note 16 to the Financial Statements includes: the Company's objectives, policies and processes for managing its financial risks; details of its financial instruments; and its exposures to market price risk, interest rate risk, liquidity risk, price risk sensitivity and credit risk. The Directors believe that the Company is well placed to manage its business risks.
Having made suitable enquiries, the Directors have a reasonable expectation that the Company has adequate financial resources to enable it to continue in operational existence for the foreseeable future and, accordingly, they have continued to adopt the going concern basis when preparing the Annual Report and Financial Statements.
The Company's financial instruments comprise its investment portfolio, cash balances and debtors and creditors that arise directly from its operations, including accrued income and purchases and sales awaiting settlement. The main risks that the Company faces arising from its financial instruments are disclosed in Note 16 to the Financial Statements.
The Company has no greenhouse gas emissions to report from its operations, nor does it have responsibility for any other emissions-producing sources under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013.
The Statement of Corporate Governance, which forms part of this Directors' Report, is shown on pages 41 to 45.
Biographies of the Directors who held office at the year end are shown in the Your Board section of this Annual Report along with their interests in the shares of the Company, which are also shown below. No Director has a service contract with the Company and no contract or arrangement significant to the Company's business and in which any of the Directors is interested has subsisted during the year.
In accordance with the Articles of Association, Directors must offer themselves for re-election at least once every three years. However, in accordance with corporate governance best practice, the Board has decided that all Directors who have served for periods in excess of nine years should stand for re-election on an annual basis. Stephen Barclay has confirmed that he intends to retire at the 2015 AGM and will not be seeking re-election.
Gregor Logan will retire and seek re-election at the 2015 AGM, this being the first following his appointment. Jonathan Carr and Brian May will each retire at the 2015 AGM, and, being eligible, offer themselves for re-election. Also, in accordance with corporate governance best practice for nonindependent Directors, Bill Nixon retires at the 2015 AGM and, being eligible, offers himself for annual re-election.
The Board confirms that, following a formal process of evaluation, the performance of each of the Directors seeking re-election continues to be effective and demonstrates commitment to the role. The Board, therefore, believes that it is in the best interests of Shareholders that each of the Directors wishing to retain office is re-elected and Resolutions to this effect will be proposed at the AGM.
The Directors who held office during the year and their interests in the share capital of the Company are as follows:
| 31 March 2015 Ordinary Shares of 50p each |
31 March 2014 Ordinary Shares of 50p each |
|
|---|---|---|
| Jonathan Carr (Chairman) | 10,000 | 10,000 |
| Stephen Barclay | 138,434 | 138,434 |
| Gregor Logan1 | 45,450 | - |
| Brian May | 261,977 | 255,000 |
| Bill Nixon | 174,179 | 174,179 |
1 Mr Logan's interest was acquired prior to his appointment as a Director on 10 February 2015. There have been no changes to the beneficial interest of the Directors subsequent to the period end.
Each Director has a statutory duty to avoid a situation where he has, or could have, a direct or indirect interest which conflicts, or may conflict, with the interests of the Company. A Director will not be in breach of that duty if the relevant matter has been authorised by the Board in accordance with the Company's Articles of Association and this includes any co-investment by the Directors in entities in which the Company also has an interest.
The Board has approved a protocol for identifying and dealing with conflicts and has resolved to conduct a regular review of actual or possible conflicts. No new material conflicts or potential conflicts were identified during the year.
Maven Capital Partners UK LLP (Maven) acted as Manager and Secretary to the Company during the year ended 31 March 2015 and details of the fees paid are disclosed in Notes 3 and 4 to the Financial Statements.
The principal terms of the Management and Administration Deed agreed with Maven are as follows:
The agreement is terminable, by either party, on the expiry of twelve months' notice in writing. Furthermore, the Company may terminate the agreement without compensation due if:
For the year ending 31 March 2016, investment management, performance and secretarial fees payable to Maven will be calculated and charged on the following basis:
Independent of the above arrangements, Maven receives a refund of any expenses incurred specific to Mr Nixon's role as a Director of the Company. Maven may also receive, from investee companies, fees in relation to arranging transactions, monitoring of business progress and for providing non-executive directors for their boards.
In addition, in order to ensure that the Manager's staff are appropriately incentivised in relation to the management of the portfolio, a co-investment scheme allows individuals to participate in new investments in portfolio companies alongside the Company. All such investments are made through a nominee and under terms agreed by the Board. The terms of the scheme ensure that all participants invest on identical terms to those of the Company and that no selection of investments will be allowed. Total investment by participants in the co-investment scheme is set at 5% of the aggregate amount of ordinary shares subscribed for, except where the only securities to be acquired by the Company are ordinary shares or are securities quoted on AIM or ISDX, in which case the co-investment percentage will be 1.5%. Any dilution of the Company's interests is, therefore, minimal and the Directors believe that the scheme provides a useful incentive which closely aligns the interests of key individuals within the Manager's staff with those of the Shareholders.
In light of investment performance achieved by the Manager, together with the standard of company secretarial and administrative services provided, the Board considers that the continued appointment of the Manager and Secretary on the stated terms is in the best interests of the Company and its Shareholders. It should be noted that, as at 10 July 2015, Maven, Bill Nixon and certain of the Manager's other executives held, in aggregate, 746,955 of the Company's Ordinary Shares, representing 10.33% of the issued capital as at that date.
The Company's independent Auditor, Deloitte LLP, is willing to continue in office and Resolution 8 to propose its reappointment will be proposed at the 2015 AGM, along with Resolution 9, to authorise the Directors to fix its remuneration. Non-audit fees for tax services amounting to £3,000 were paid to Deloitte LLP during the year under review (2014: £3,000). The Directors have received confirmation from the Auditor that it remains independent and objective. The Directors have also reviewed the Auditor's procedures in connection with the provision of non-audit services and remain satisfied that objectivity and independence is being safeguarded by Deloitte LLP.
So far as the Directors who held office at the date of approval of this Report are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the Company's Auditor is unaware, and each of the Directors has taken all the steps that he ought to have taken as a Director in order to make himself aware of any relevant audit information and to establish that the Company's Auditor is aware of that information.
The Company has authority to make market purchases of its own shares, although no such transactions have been effected during the year ended 31 March 2015. A Special Resolution, numbered 12 in the Notice of Meeting, will be put to Shareholders at the 2015 AGM for their approval to renew the Company's authority to purchase in the market a maximum of 1,084,204 Ordinary Shares (14.99% of the shares in issue at 10 July 2015). Such authority will expire on the date of the AGM in 2016 or after a period of 15 months from the date of the passing of the Resolution, whichever is the earlier.
Purchases of shares will be made within guidelines established from time to time by the Board, but only if it is considered that such purchases would be to the advantage of the Company and its Shareholders when taken as a whole. Purchases will be made in the market at prices below the prevailing NAV per share. Under the Listing Rules of the UK Listing Authority, the maximum price that may be paid on the exercise of this authority must not exceed 105% of the average of the mid-market quotations for the shares over the five business days immediately preceding the date of purchase. The minimum price that may be paid is 10p per share. In making purchases, the Company will deal only with member firms of the London Stock Exchange. Any shares which are purchased will be cancelled.
Purchases of shares by the Company will be made from distributable reserves and will normally be paid out of cash balances held by the Company from time to time. As any purchases will be made at a discount to the prevailing NAV, the NAV of the remaining Ordinary Shares in issue should increase as a result of any such purchase. Shares will not be purchased by the Company in the period of 60 days immediately preceding the notification of the Company's Interim Report and the 60 days immediately preceding the announcement of the Annual Report or, if shorter, the period from the end of the Company's relevant financial period up to and including the earlier of an announcement of all price sensitive information in respect of the relevant period or the release of the full results.
During the year under review, 825,164 new Ordinary Shares (2014: 1,098,586) were allotted under an Offer for Subscription. An Ordinary Resolution, numbered 10 in the Notice of Meeting, will be put to Shareholders at the 2015 AGM for their approval for the Company to issue up to an aggregate nominal amount of £361,642 (equivalent to 723,284 Ordinary Shares or 10% of the total issued share capital at 10 July 2015).
Issues of new Ordinary Shares may only be made at, or at a premium to, NAV per share, thus ensuring existing investors will not be disadvantaged by such issues. The proceeds of any issue may be used to purchase the Company's shares in the market or to fund further investments in accordance with the Company's investment policy. This authority shall expire either at the conclusion of the AGM in 2016 or on the expiry of 15 months from the passing of the Resolution, whichever is the first to occur.
When shares are to be allotted for cash, Section 561(1) of the Companies Act 2006 provides that existing Shareholders have pre-emption rights and that the new shares are offered first to such Shareholders in proportion to their existing shareholdings. However, Shareholders can, by special resolution, authorise the Directors to allot shares otherwise than by a pro rata issue to existing Shareholders. A Special Resolution, numbered 11 in the Notice of Meeting, will, if passed, give the Directors power to allot, for cash, Ordinary Shares up to an aggregate nominal amount of £361,642 (equivalent to 723,284 Ordinary Shares or 10% of the total issued share capital at 10 July 2015) as if Section 561(1) does not apply. This is the same amount of share capital that the Directors are seeking the authority to allot pursuant to Resolution 10. The authority will also expire either at the conclusion of the AGM of the Company in 2016 or on the expiry of 15 months from the passing of the Resolution, whichever is the first to occur.
As at 10 July 2015 the Company's share capital amounted to 7,232,852 Ordinary Shares of 50p each.
Other than those set out in this Directors' Report, there are no further related party transactions that require to be disclosed.
There have been no events since 31 March 2015 that require disclosure.
The Annual General Meeting will be held on 3 September 2015, and the Notice of Annual General Meeting is on pages 71 to 76 of this Annual Report. The Notice of Annual General Meeting also contains a Resolution that seeks authority for the Directors to convene a General Meeting, other than an Annual General Meeting, on not less than fourteen days' clear notice.
The Directors consider that all of the Resolutions to be put to the Annual General Meeting are in the best interests of the Company and its Shareholders as a whole. Your Board will be voting in favour of them and unanimously recommends that you do so as well.
By order of the Board Maven Capital Partners UK LLP Secretary
17 July 2015
This report has been prepared in accordance with the requirements of Section 421 of the Companies Act 2006 and the Enterprise and Regulatory Reform Act 2013. An Ordinary Resolution for the approval of this Report will be put to the Members of the Company at the forthcoming AGM. The law requires the Company's Auditors to audit certain of the disclosures provided. Where disclosures have been audited, they are indicated as such and the Auditor's opinion is included in their report on pages 51 to 54. The report includes a section on the Company's policy for the remuneration of its Directors.
The Directors have established a Remuneration Committee comprising all of the independent Directors and with Jonathan Carr as its Chairman. As all of the Directors are non-executive, the Principles of the UK Code on Corporate Governance in respect of executive directors' remuneration do not apply.
At 31 March 2015, the Company had five non-executive Directors and their biographies are shown in the Your Board section of this Annual Report. The names of the Directors who served during the year, together with the fees paid to them during the year, are shown in the table on page 39.
The dates of appointment of the Directors in office as at 31 March 2015, and the dates on which they will next be proposed for re-election are, as follows:
| Date of original appointment |
Due date for re-election |
|
|---|---|---|
| Jonathan Carr (Chairman) | 22 March 2000 | 3 September 2015 |
| Stephen Barclay | 22 March 2000 | Retiring in August 2015 |
| Gregor Logan | 10 February 2015 | 3 September 2015 |
| Brain May | 22 March 2000 | 3 September 2015 |
| Bill Nixon | 21 February 2006 | 3 September 2015 |
During the year ended 31 March 2015, the Board was not provided with advice or services by any person in respect of its consideration of the Directors' remuneration. However, in the application of the Board's policy on Directors' remuneration, as defined below, the Committee expects, from time to time, to review the fees paid to the directors of other venture capital trust companies.
At a meeting held during the year ended 31 March 2015, the Committee carried out a review of Directors' fees and concluded that there would be no change to the level of the remuneration of the independent Directors. It was also agreed that the policy would be to continue to review these rates on a regular basis.
The chart below shows, for the years ended 31 March 2015 and 31 March 2014, the cost of Directors' fees compared with the level of dividend distribution. (£'000)
As noted in the Strategic Report, all of the Directors are non-executive and, therefore, the Company does not have a chief executive officer, nor does it have any employees. In the absence of a chief executive officer or employees, there is no related information to disclose.
At the Annual General Meeting held in August 2014, the results in respect of Ordinary Resolutions to approve the Directors' Remuneration Report for the year ended 31 March 2014 and the Directors' remuneration policy for the three year period ending 31 March 2017 were as follows:
| Percentage of votes cast for |
Percentage of votes cast against |
Number of votes withheld |
|
|---|---|---|---|
| Remuneration Report | 99.8 | 0.2 | 560 |
| Remuneration Policy | 98.0 | 2.0 | 560 |
The Company purchases and maintains liability insurance covering the Directors and Officers of the Company. This insurance is not a benefit in kind, nor does it form part of the Directors' remuneration.
The Board is responsible for the Company's investment strategy and performance, although the day to day management of the Company's investment portfolio is delegated to the Manager through the investment management agreement, as referred to in the Directors' Report.
The graph below compares the total returns on an investment of £100 in the Ordinary Shares of the Company, for each annual accounting period for the five years to 31 March 2015, assuming all dividends are reinvested, with the total shareholder return on a notional investment of £100 made up of shares of the same kind and number as those by reference to which the FTSE AIM All-Share index is calculated. This index was chosen for comparison purposes as it is the most relevant to the Company's investment portfolio.
The Directors who served during the year received the following emoluments in the form of fees:
| 31 March 2015 £ |
31 March 2014 £ |
|
|---|---|---|
| Jonathan Carr (Chairman) | 6,500 | 6,500 |
| Stephen Barclay | 5,000 | 5,000 |
| Gregor Logan1 | - | - |
| Brian May | 5,000 | 5,000 |
| Bill Nixon | - | - |
| Total | 16,500 | 16,500 |
1 Mr Logan was appointed on 10 February 2015 and his remuneration is effective from 3 September 2015
These amounts exclude any employers' national insurance contributions, if applicable. No other forms of remuneration were received by the Directors and no Director received any taxable expenses, compensation for loss of office or non-cash benefit for the year ended 31 March 2015 (2014: £nil).
The Directors' Interests in the share capital of the Company are shown in the Directors' Report on page 34. There is no requirement for Directors to hold shares in the Company.
The Company's policy is that the remuneration of the Directors, all of whom are non-executive, should reflect the experience of the Board as a whole and be fair and comparable to that of other venture capital trusts with a similar capital structure and similar investment objectives. Directors are remunerated in the form of fees, payable quarterly in arrears, to the Director personally or to a third party specified by him or her. The fees for the Directors are determined within the limits set out in the Company's Articles of Association, which limit the aggregate of the fees payable to the Directors to £250,000 per annum and the approval of Shareholders in a General Meeting would be required to change this limit.
It is intended that the fees payable to the Directors should reflect their duties, responsibilities, and the value and amount of time committed to the Company's affairs, and should also be sufficient to enable candidates of a high quality to be recruited and retained. Non-executive Directors do not receive bonuses, pension benefits, share options, long-term incentive schemes or other benefits, and the fees are not specifically related to the Directors' performance, either individually or collectively.
The Company does not have any employees and Directors' remuneration comprises solely of Directors' fees. The current and projected Directors' fees for the year ended 31 March 2015 and the year ending 31 March 2016 respectively are shown below.
| Year ending 31 March 2016 £ |
Year ended 31 March 2015 £ |
|
|---|---|---|
| Jonathan Carr (Chairman) | 6,500 | 6,500 |
| Stephen Barclay1 | 2,131 | 5,000 |
| Gregor Logan2 | 2,869 | - |
| Brain May | 5,000 | 5,000 |
| Total | 16,500 | 16,500 |
1 Mr Barclay will retire at the AGM on 3 September 2015
2 Mr Logan was appointed on 10 February 2015 and his remuneration is effective from 3 September 2015
Directors do not have service contracts, but new Directors are each provided with a letter of appointment. The terms of appointment provide that Directors should retire and be subject to re-election at the first Annual General Meeting after their appointment. Thereafter, the Company's Articles of Association require all Directors to retire by rotation at least every three years. There is no notice period and no provision for compensation upon early termination of appointment, save for any arrears of fees which may be due.
During the year ended 31 March 2015, no communication has been received from Shareholders regarding Directors' remuneration. The remuneration policy and the level of fees payable is reviewed annually by the Remuneration Committee and it is intended that the current policy will continue for the year ending 31 March 2016. It is the Board's intention that the remuneration policy will be put to a Shareholders' vote at least once every three years and, as a
Resolution was approved at the AGM held in 2014, an Ordinary Resolution for its approval will next be proposed at the AGM to be held in 2017.
The Directors' Remuneration Report was approved by the Board of Directors and signed on its behalf by:
Jonathan Carr Director 17 July 2015
40 MAVEN INCOME AND GROWTH VCT 6 PLC
The Company is committed to, and is accountable to the Company's Shareholders for, a high standard of corporate governance. The Board has put in place a framework for corporate governance that it believes is appropriate for a venture capital trust and which enables it to comply with the UK Code of Corporate Governance (the Code), published in September 2012. The Code is available from the website of the Financial Reporting Council at www.frc.org.uk.
The Company is not a member of the AIC. However, it is recognised that the AIC has published its own Code on Corporate Governance (the AIC Code) and the AIC Corporate Governance Guide for Investment Companies (the AIC Guide). These were both revised in February 2013 and provide a comprehensive guide to best practice in certain areas of governance where the specific characteristics of investment trusts or venture capital trusts suggest alternative approaches to those set out in the Code. Both the AIC Code and AIC Guide are available from the AIC website at www.theaic.co.uk.
This Statement of Corporate Governance forms part of the Directors' Report.
This statement describes how the main principles identified in the Code and the AIC Code (the Codes) have been applied by the Company throughout the year as is required by the Listing Rules of the UK Listing Authority. In instances where the Code and AIC Code differ, an explanation will be given as to which governance code has been applied, and the reason for that decision.
The Board is of the opinion that the Company has complied fully with the main principles identified in the Codes, except as set out below and in the Report by the Audit and Risk Committees:
In the relevant sections of this Statement of Corporate Governance, the Board has reported further in the respect of the above provisions.
The Board currently consists of five male Directors, all of whom are non-executive and the majority of whom are considered to be independent of the investment manager (Maven Capital Partners UK LLP, Maven, or the Manager) and free of any relationship which could materially interfere with the exercise of their independent judgement. However, the following points should be noted;
The biographies of the Directors appear in the Your Board section of this Annual Report and indicate their high level and range of investment, industrial, commercial and professional experience.
The Board sets the Company's values and objectives and ensures that its obligations to Shareholders are met. It has formally adopted a schedule of matters which are required
to be brought to it for decision, thus ensuring that it maintains full and effective control over appropriate strategic, financial, operational and compliance issues. These matters include:
As required by the Companies Act 2006 and permitted by the Articles of Association, Directors notify the Company of any situation which might give rise to the potential for a conflict of interest, so that the Board may consider and, if appropriate, approve such situations. A register of potential conflicts of interest for Directors is reviewed regularly by the Board and the Directors notify the Company whenever there is a change in the nature of a registered conflict, or whenever a new conflict situation arises.
Following implementation of the Bribery Act 2010, the Board adopted appropriate procedures.
There is an agreed procedure for Directors to take independent professional advice, if necessary, at the Company's expense.
The Directors have access to the advice and services of the corporate Company Secretary through its appointed representatives who are responsible to the Board for:
An induction meeting will be arranged by the Manager on the appointment of any new Director, covering details about the Company, the Manager, legal responsibilities and venture capital industry matters. Directors are provided, on a regular basis, with key information on the Company's policies, regulatory and statutory requirements and internal controls. Changes affecting Directors' responsibilities are advised to the Board as they arise.
Jonathan Carr is Chairman of the Company and is also Chairman of the Audit, Management Engagement, Nomination, Remuneration and Risk Committees, as the other Directors consider that he has the skills and experience relevant to these roles. The Board has not appointed a Senior Independent Non-executive Director.
The Board meets at least four times each year and, between Meetings, maintains regular contact with the Manager. The primary focus of quarterly Board Meetings is a review of investment performance and related matters including asset allocation, peer group information and industry issues. During the year ended 31 March 2015, the Board held four full Board Meetings and seven Board Committee Meetings. In addition, there were two Meetings of the Audit and Nomination Committees, three Meetings of the Risk Committee and one Meeting each of the Management Engagement and Remuneration Committees.
| Board | Board Committee |
Audit Committee |
Management Engagement Committee |
Nomination Committee |
Remuneration Committee |
Risk Committee |
|
|---|---|---|---|---|---|---|---|
| Jonathan Carr (Chairman) | 4 (4) | 7 (7) | 2 (2) | 1 (1) | 2 (2) | 1 (1) | 3 (3) |
| Stephen Barclay | 2 (4) | 7 (7) | 1 (2) | - (1) | 1 (2) | - (1) | 2 (3) |
| Gregor Logan2 | 1 (1) | - (-) | 1 (1) | 1 (1) | 1 (1) | 1 (1) | 1 (1) |
| Brian May | 4 (4) | 7 (7) | 2 (2) | 1 (1) | 2 (2) | 1 (1) | 3 (3) |
| Bill Nixon3 | 4 (4) | 7 (7) | - (-) | - (-) | - (-) | - (-) | - (-) |
Directors have attended Board and Committee Meetings during the year ended 31 March 20151 as follows:
1 The number of meetings which the Directors were eligible to attend is in brackets.
2 Appointed 10 February 2015.
3 Bill Nixon is not a member of the Audit, Management Engagement, Nomination, Remuneration and Risk Committees. To enable the Board to function effectively and allow Directors to discharge their responsibilities, full and timely access is given to all relevant information. In the case of Board Meetings, this consists of a comprehensive set of papers, including the Manager's review and discussion documents regarding specific matters. The Directors make further enquiries when necessary.
The Board and its Committees have undertaken a process for their annual performance evaluation, using questionnaires and discussion to ensure that Directors have devoted sufficient time and contributed adequately to the work of the Board and its Committees. The Chairman is subject to evaluation by his fellow Directors.
The Company's Articles of Association require all Directors to retire by rotation at least every three years. However, in accordance with corporate governance best practice, the Board has decided that all Directors who have served for periods in excess of nine years should stand for re-election on an annual basis. Also in accordance with corporate governance best practice, as a non-independent Director, Bill Nixon stands for election at each AGM.
The Board subscribes to the view expressed in the AIC Code that long-serving Directors should not be prevented from forming part of an independent majority. It does not consider that a Director's tenure necessarily reduces his ability to act independently and, following formal performance evaluations, believes that each Director is independent in character and judgement and that there are no relationships or circumstances which are likely to affect the judgement of any Director.
The Board's policy on tenure is that continuity and experience are considered to add significantly to the strength of the Board and, as such, no limit on the overall length of service of any of the Company's Directors, including the Chairman, has been imposed. The Company has no executive Directors or employees.
Each of the Committees has been established with written terms of reference and comprises members that are independent and free from any relationship that would interfere with important judgement in carrying out their responsibilities. The terms of reference of each of the Committees, which are available on request from the Registered Office of the Company, are reviewed and reassessed for their adequacy at each Meeting.
The Audit Committee is chaired by Jonathan Carr and comprises all independent Directors. The role and responsibilities of the Committee are detailed in a joint Report by the Audit and Risk Committees.
The Management Engagement Committee, which comprises all independent Directors and is chaired by Jonathan Carr, is responsible for the annual review of the management contract with the Manager, details of which are shown in the Directors' Report. One Meeting was held during the year ended 31 March 2015, at which the Committee recommended the continued appointment of Maven Capital Partners UK LLP as Manager of the Company.
The Nomination Committee, which comprises all independent Directors and is chaired by Jonathan Carr, held two Meetings during the year ended 31 March 2015. The Committee makes recommendations to the Board on the following matters:
At its Meeting in February 2015, the Nomination Committee recommended that the Board should adopt a succession plan through which Mr Barclay and Mr Carr would stand down respectively at the Annual General Meetings to be held in 2015 and 2016. In accordance with this recommendation it was confirmed that Mr Barclay would retire at the Annual General Meeting to be held on 3 September 2015, and would not stand for re-election. The Committee also recommended the appointment of Gregor Logan, which was confirmed by the Board on 10 February 2015, and he will stand for re-election by Shareholders at the 2015 AGM.
The performance of the Board, Committees and individual Directors was evaluated through an assessment process, led by the Chairman and the performance of the Chairman was evaluated by the other Directors. While the Company does not have a formal policy on diversity, Board diversity forms part of the responsibilities of the Committee.
Where a venture capital trust has only non-executive directors, the Code principles relating to directors' remuneration do not apply. However, the Company does have a Remuneration Committee, comprising all of the independent Directors which is chaired by Jonathan Carr. The Committee held one Meeting during the year ended 31 March 2015 to review the policy for, and the level of, Directors' Remuneration.
The level of remuneration of the Directors has been set in order to attract and retain individuals of a calibre appropriate to the future development of the Company. Details of the remuneration of each Director and of the Company's policy on Directors' Remuneration are provided in the Directors' Remuneration Report.
A Risk Committee was established during the year under review, is chaired by Jonathan Carr and comprises all independent Directors. The role and responsibilities of the Committee are detailed in a joint Report by the Audit and Risk Committees.
The Board has contractually delegated to external agencies, including the Manager, certain services: the management of the investment portfolio, the custodial services (which include the safeguarding of assets), the registration services and the day to day accounting and company secretarial requirements. Each of these contracts was entered into after full and proper consideration by the Board of the quality and cost of services offered. The Board receives and considers reports from the Manager and other external agencies on a regular basis. In addition, ad hoc reports and information are supplied to the Board as requested.
The Financial Reporting Council (FRC) published the UK Stewardship Code (the Stewardship Code) for institutional shareholders on 2 July 2010 and this was revised in September 2012. The purpose of the Stewardship Code is to enhance the quality of engagement between institutional investors and companies to help improve long-term returns to shareholders and assist institutional investors in the efficient exercise of their governance responsibilities.
The Board is aware of its duty to act in the interests of the Company and the Directors believe that the exercise of voting rights lies at the heart of regulation and the promotion of good corporate governance. The Directors, through the Manager, would wish to encourage companies in which investments are made to adhere to best practice in the area of corporate governance. The Manager believes that, where practicable, this can best be achieved by entering into a dialogue with investee company management teams to encourage them, where necessary, to improve their governance policies. Therefore, the Board has delegated responsibility for monitoring the activities of portfolio companies to the Manager and has given it discretionary powers to vote in respect of the holdings in the Company's investment portfolio.
The Directors and the Manager are aware of their duty to act in the interests of the Company and acknowledge that there are risks associated with investment in companies which fail to conduct business in a socially responsible manner. Therefore, the Directors and the Manager take account of the social environment and ethical factors that may affect the performance or value of the Company's investments. Maven and the Directors believe that a company run in the longterm interests of its shareholders should manage its relationships with its employees, suppliers and customers and behave responsibly towards the environment and society as a whole.
The Company places a great deal of importance on communication with its Shareholders and all are welcome to attend and participate in the Annual General Meeting. The Notice of Meeting sets out the business of the Annual General Meeting and the Resolutions are explained more fully in the Explanatory Notes to the Notice of Annual General Meeting as well as the Directors' Report and the Directors' Remuneration Report. Separate Resolutions are proposed for each substantive issue and Shareholders have the opportunity to put questions to the Board and to the Manager. The results of proxy voting are relayed to Shareholders after each Resolution has been voted on by a show of hands. Nominated persons, often the beneficial owners of shares held for them by nominee companies, may attend Shareholder Meetings and are invited to contact the registered Shareholder, normally a nominee company, in the first instance in order to be nominated to attend and to vote in respect of the shares held for them. It is in the nature of a venture capital trust that it generally has few major shareholders.
As recommended under the Code, the Annual Report is normally published at least twenty business days before the Annual General Meeting. Annual and Interim Reports and Financial Statements are distributed to Shareholders and other parties who have an interest in the Company's performance.
Shareholders and potential investors may obtain up-to-date information on the Company through the Manager and the Secretary, and the Company responds to letters from Shareholders on a wide range of issues. In order to ensure that the Directors develop an understanding of the views of Shareholders, correspondence between Shareholders and the Manager or the Chairman is copied to the Board. The Company's web pages are hosted on the Manager's website, and can be visited at www.mavencp.com/migvct6 from where Annual and Interim Reports, Stock Exchange Announcements and other information can be viewed, printed or downloaded. Further information about the Manager can be obtained from www.mavencp.com.
The Statement of Directors' Responsibilities in respect of the Financial Statements is on page 46 and the Statement of Going Concern is included in the Directors' Report on page 33. The Independent Auditor's Report is on pages 51 to 54.
By order of the Board Maven Capital Partners UK LLP Secretary
17 July 2015
The Directors are responsible for preparing the Annual Report, Directors' Remuneration Report and the Financial Statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare Financial Statements for each financial year. Under that law, the Directors have elected to prepare the Financial Statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). The Financial Statements are required by law to give a true and fair view of the state of affairs of the Company and of the net return of the Company for that period.
In preparing these Financial Statements, the Directors are required to:
The Directors are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the Financial Statements comply with the Companies Act. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors are also responsible for preparing a Strategic Report, Directors' Report, Directors' Remuneration Report (including a report on remuneration policy) and Corporate Governance Statement that comply with applicable law and regulations.
The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the Company's webpages, which are hosted on the Manager's website. Legislation in the United Kingdom governing the preparation and dissemination of Financial Statements may differ from legislation in other jurisdictions.
The Directors are also responsible for ensuring that the Annual Report and Financial Statements, taken as a whole, are fair, balanced and understandable and provide the information necessary to assess the Company's performance and strategy.
The Directors believe that, to the best of their knowledge:
By order of the Board Maven Capital Partners UK LLP Secretary 17 July 2015
Under the recommendations of AIFMD, the Company has established a Risk Committee with separate responsibilities from those of the Audit Committee. Both Committees are chaired by Jonathan Carr and comprise all independent Directors.
The principal responsibilities of the Audit Committee include:
The Board is satisfied that at least one member of the Committee has recent and relevant financial experience.
The Committee met twice during the year under review, in May and November 2014, and at each Meeting considered the key risks detailed above and the corresponding internal control and risk reports provided by the Manager which included the Company's Risk Management Framework (the Framework). No significant weaknesses in the control environment were identified and it was also noted that there had not been any adverse comment from the Auditor and that the Auditor had not identified any significant issues in its audit report. The Committee, therefore, concluded that there were no significant issues which required to be reported to the Board.
At its meeting in May 2014, the Committee reviewed the Framework in light of AIFMD and the related changes to the relationship between the Company and its Investment Manager. In addition, the Committee reviewed the new requirements for the Annual Report in relation to narrative reporting, enhanced audit reporting and the 2012 Corporate Governance Code. The Committee also considered the draft Annual Report and Financial Statements for the year ended 31 March 2014, along with the amount of the final dividend for the year then ended.
At its meeting in November 2014, the Committee reviewed the Half Yearly Report for the six months ended 30 September 2014 and also considered the performance of Deloitte LLP (Deloitte) as Auditor, and its independence and tenure. The Committee concluded that it was satisfied with the performance of Deloitte and recommended its continued appointment, with there being no requirement to put the provision of audit services out to tender at that time. The Committee agreed that this matter would be reviewed in 2015.
Subsequent to 31 March 2015, the Committee also considered the draft Annual Report and Financial Statements for the year ended 31 March 2015 and provided advice to the Board that it considered that the Annual Report and Financial Statements, taken as a whole, were fair, balanced and understandable and provided the information necessary for Shareholders to assess the Company's performance and strategy.
It is recognised that the portfolio forms a significant element of the Company's assets and that there are different risks associated with listed and unlisted investments. The primary risk that requires the particular attention of the Committee is that unlisted investments are not recognised and measured in line with the Company's stated accounting policy on the valuation of investments as set out in Note 1(e) to the Financial Statements on page 60. In accordance with that policy, unlisted investments are valued by the Manager and are subject to scrutiny and approval by the Directors. Investments listed on a recognised stock exchange are valued at their bid market price.
The Audit Committee has considered the assumptions and judgements in relation to the valuation of each quoted and unquoted investment and is satisfied that they are appropriate.
| Investment | % of net assets by value |
Valuation basis |
|---|---|---|
| Quoted | 3.1 | Bid price1 |
| Unlisted | 77.3 | Directors' valuation2 |
| Total investment | 80.4 |
1 London Stock Exchange closing market quote.
2 Directors' valuation represents an independent third party valuation or either of: (i) an earnings multiple basis; (ii) cost; or (iii) a provision against cost where there may be a diminution in value due to a company's underperformance. Where an earnings multiple or cost less impairment is not appropriate, or other overriding factors apply, a discounted cash flow or net asset value basis may be applied.
The Committee recommended the investment valuations, representing 80.4% of net assets as at 31 March 2015, to the Board for approval. In addition, the revenue generated from dividend income and loan stock interest has been considered by the Committee on a quarterly basis and the Directors are satisfied that the levels of income recognised are in line with revenue estimates.
As part of its annual review of audit services, the Committee considers the performance, cost effectiveness and general relationship with the Auditor. In addition, the Committee reviews the independence and objectivity of the external auditor. The Company first appointed Deloitte, then Deloitte & Touche LLP, as Auditor for the year ended 31 March 2008. The Independent Auditor's Report is on pages 51 to 54 and it should be noted that Deloitte rotates the Senior Statutory Auditor responsible for the audit every five years. The Senior Statutory Auditor at Deloitte was last changed after the conclusion of the audit for the year ended 31 March 2012. Details of the amounts paid to the Auditor during the year for audit and other services are set out in Note 4 to the Financial Statements.
The Company has in place a policy governing and controlling the provision of non-audit services by the external Auditor, so as to safeguard their independence and objectivity. Shareholders are asked to approve the re-appointment, and the Directors' responsibility for the remuneration, of the Auditor at each Annual General Meeting. Any non-audit work, other than interim reviews, requires the specific approval of the Audit Committee in each case. Non-audit work, where independence may be compromised or conflicts arise, is prohibited. There are no contractual obligations which restrict the Committee's choice of Auditor. However, in light of recent EU regulation and FRC guidance on audit tenders, the Committee is mindful that the audit will require to be put out to tender and will continue to keep the tenure of the Auditor under review. The Board has concluded that Deloitte is independent of the Company and recommended that a Resolution for the re-appointment of Deloitte as external Auditor should be put to the 2015 AGM.
The Risk Committee held three Meetings during the year under review. The responsibilities of the Committee are:
to ensure that the risk profile of the Company corresponds to the size, portfolio structure and investment strategies and objectives of the Company;
to report to the Board on its conclusions and to make recommendations in respect of any matters within its remit including proposals for improvement in, or changes to, the systems, processes and procedures that are in place;
The Committee will review these terms of reference at least once each year.
The Board of Directors of Maven Income and Growth VCT 6 PLC has overall responsibility for the Company's system of internal control and for reviewing its effectiveness, and has considered the requirement for an internal audit function as recommended by provision 3.6 of the AIC Code. However, as the Directors have delegated the investment management, company secretarial and administrative functions of the Company to the Manager, the Board considers that it is appropriate for the Company's internal controls to be monitored by the Manager, rather than by the Company itself. The Directors have confirmed that there is an ongoing process for identifying, evaluating and managing the significant risks faced by the Company, which has been in place up to the date of approval of the Annual Report and Financial Statements. This process is reviewed regularly by the Board and accords with internal control guidance issued by the FRC.
The Board has reviewed the effectiveness of the system of internal control and, in particular, it has reviewed the process for identifying and evaluating the significant risks affecting the Company and the policies and procedures by which these risks are managed. The Directors have delegated the management of the Company's assets to the Manager and this embraces implementation of the system of internal control, including financial, operational and compliance controls and risk management. Internal control systems are monitored and supported by the compliance function of the Manager, which undertakes periodic examination of business processes, including compliance with the terms of the Management and Administration Deed, and ensures that recommendations to improve controls are implemented.
Risks are identified through a risk management framework by each function within the Manager's activities. Risk is considered in the context of the guidance issued by the FRC and includes financial, regulatory, market, operational and reputational risk. This helps the Manager's risk model identify those functions most appropriate for review. Any errors or weaknesses identified are reported to the Company and timetables are agreed for implementing improvements to systems. The implementation of any remedial action required is monitored and feedback provided to the Board.
The key components designed to provide effective internal control for the year under review and up to the date of this report are:
The internal control systems are intended to meet the Company's particular needs and the risks to which it is exposed. Accordingly, these systems are designed to manage, rather than eliminate, the risk of failure to achieve business goals and, by their nature, can provide reasonable, but not absolute, assurance against material misstatement or loss.
In terms of the assessment of the key risks facing the Company, it is recognised that the investment portfolio forms a significant element of its assets. The recognition, ownership and valuation of the investment portfolio is therefore an area of particular attention for the Committee. Specifically, the risk is that investments are not recognised and measured in line with the Company's stated accounting policy on the valuation of investments as set out in Note 1(e) to the Financial Statements on page 60. As revenue generated from dividend income and loan stock interest is the major source of revenue and a significant item in the Income Statement, another key risk relates to the recognition of investment income and, specifically, that the Company does not recognise income in line with its stated policy. The maintenance of VCT status is another key risk that the Company has to consider and the approach to address each of these key risks is set out below.
The Company uses the services of an independent Custodian (JP Morgan Chase) to hold the quoted investment assets of the Company. An annual internal control report is received from the Custodian which provides details of the Custodian's control environment. The investment portfolio is reconciled regularly by the Manager and the reconciliation is also reviewed by the Auditor. The portfolio is reviewed and verified by the Manager on a regular basis and management accounts, including a full portfolio listing, are considered at the quarterly meetings of the Board. The portfolio is also audited annually by the Auditor.
The valuation of investments is undertaken in accordance with the Company's stated accounting policy as set out in Note 1(e) to the Financial Statements on page 60. Unlisted investments are valued by the Manager and are subject to scrutiny and approval by the Directors. Investments listed on a recognised stock exchange are valued at their bid market price. The Committee considered and challenged the assumptions and significant judgements in relation to the valuation of each quoted and unquoted investment and was satisfied that they were appropriate. The Committee was also satisfied that there were no issues associated with the existence and ownership of the investments which required to be addressed.
The recognition of dividend income and loan stock interest is undertaken in accordance with accounting policy Note 1(b) to the Financial Statements on page 59. Management accounts are reviewed by the Board on a quarterly basis and discussion takes place with the Manager at the quarterly Board Meetings regarding the revenue generated from dividend income and loan stock. The Committee is satisfied that the levels of income recognised are in line with revenue estimates and that there were no issues associated with revenue recognition which required to be addressed.
Compliance with the VCT regulations is monitored continually by the Manager and is reviewed by the Committee on a quarterly basis. The Committee concluded that there were no issues associated with the maintenance of VCT status that required to be addressed.
The principal risks and uncertainties faced by the Company and the Board's strategy for managing these risks, is also covered in the Business Report on pages 13 to 15.
Jonathan Carr Director 17 July 2015
In our opinion the Financial Statements:
The Financial Statements comprise the Income Statement, Reconciliation of Movements in Shareholders' Funds, Balance Sheet, Cash Flow Statement, and the related Notes 1 to 16. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
As required by the Listing Rules we have reviewed the Directors' statement on page 33 that the Company is a going concern. We confirm that:
However, because not all future events or conditions can be predicted, this statement is not a guarantee as to the Company's ability to continue as a going concern.
The assessed risks of material misstatement described below are those that had the greatest effect on our audit strategy, the allocation of resources in the audit, and directing the efforts of the engagement team:
| Risk | How the scope of our audit responded to the risk |
|---|---|
| The valuation of unlisted investments £3.2 million of the VCT's net assets are in unlisted investments where there is no readily available market price, and there is a risk that the valuation attributed to these investments is inappropriate due to significant management judgment required. The Company's fair value measurement policy is disclosed within Note 1(f). |
We have challenged the valuation of investments by obtaining an understanding of the methodology used by the Manager, considering whether this is consistent with industry practice and the International Private Equity and Venture Capital Valuation Guidelines. We obtained third party evidence that underpins inputs to the valuation, as well as testing the arithmetical accuracy of the valuation calculation. In addition, we attended the year end Audit Committee meeting where we assessed the effectiveness of the Audit Committee's challenge and approval of unlisted investment valuations. |
| The ownership of investments £3.4 million of the VCT's net assets are held in investments. There is a risk that investments recorded are not valid assets of the VCT. Details of investments are disclosed within Note 8. |
We tested 100% of the investment ownership by verifying the portfolio to either share certificates, loan stock confirmations or custodian confirmations. We have also reviewed and challenged the paper prepared by the Manager for the Risk Committee on the process for identifying, evaluating and managing the controls over the custodian's operations. |
| Revenue recognition The Company's principal revenue sources are dividends and loan stock interest. There is a risk that the misstatement of revenue could result in incorrect dividend payments. The Company's revenue recognition policy is disclosed within Note 1(b). |
We have tested a sample of dividend income receipts to bank statements to confirm they have been correctly recorded. We have reviewed and challenged the Manager's assertions regarding the ageing of accrued income and assessed its recoverability for a sample of balances. Additionally we have reviewed and challenged the Manager's assertions regarding recoverability of a sample of balances outstanding at the year end with reference to the latest performance of the Company and payments received in the year. |
The description of risks above should be read in conjunction with the significant issues considered by the Audit and Risk Committees discussed on pages 47 to 50. These risks are unchanged from the 2014 report.
Our audit procedures relating to these matters were designed in the context of our audit of the Financial Statements as a whole, and not to express an opinion on individual accounts or disclosures. Our opinion on the Financial Statements is not modified with respect to any of the risks described above, and we do not express an opinion on these individual matters.
We define materiality as the magnitude of misstatement in the Financial Statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be changed or influenced. We use materiality both in planning the scope of our work and in evaluating the results of our work.
We determined materiality for the Company to be £83,000 (2014: £105,000), which is approximately 2% (2014: 3%) of total Shareholders' equity at the year end.
This is a change of approach from 2014, where we used a materiality of 3% of total Shareholders' equity. We have changed the percentage applied to align more closely with other comparable companies.
We agreed with the Audit Committee that we would report to the committee all audit differences in excess of £1,600 (2014: £2,000), as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds. We also report to the Audit Committee on disclosure matters that we identified when assessing the overall presentation of the Financial Statements.
Our audit was scoped by obtaining an understanding of the entity and its environment, including internal control, and assessing the risks of material misstatement. Audit work to respond to the risks of material misstatement was performed directly by the audit engagement team.
In our opinion:
Under the Companies Act 2006 we are required to report to you if, in our opinion:
We have nothing to report in respect of these matters.
Under the Companies Act 2006 we are also required to report if in our opinion certain disclosures of Directors' remuneration have not been made or the part of the Directors' Remuneration Report to be audited is not in agreement with the accounting records and returns. We have nothing to report arising from these matters.
Under the Listing Rules we are also required to review the part of the Corporate Governance Statement relating to the Company's compliance with ten provisions of the UK Corporate Governance Code. We have nothing to report arising from our review.
Under International Standards on Auditing (UK & Ireland), we are required to report to you if, in our opinion, information in the Annual Report is:
In particular, we are required to consider whether we have identified any inconsistencies between our knowledge acquired during the audit and the Directors' statement that they consider the Annual Report is fair, balanced and understandable and whether the Annual Report appropriately discloses those matters that we communicated to the Audit Committee which we consider should have been disclosed. We confirm that we have not identified any such inconsistencies or misleading statements.
As explained more fully in the Directors' Responsibilities Statement the Directors are responsible for the preparation of the Financial Statements and for being satisfied that they give a true and fair view. Our responsibility is to audit and express an opinion on the Financial Statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors. We also comply with International Standard on Quality Control 1 (UK and Ireland). Our audit methodology and tools aim to ensure that our quality control procedures are effective, understood and applied. Our quality controls and systems include our dedicated professional standards review team and independent partner reviews.
This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, or for the opinions we have formed.
An audit involves obtaining evidence about the amounts and disclosures in the Financial Statements sufficient to give reasonable assurance that the Financial Statements are free from material misstatement, whether caused by fraud or error. This includes an assessment of: whether the accounting policies are appropriate to the Company's circumstances and have been applied consistently and adequately disclosed; the reasonableness of significant accounting estimates made by the directors; and the overall presentation of the Financial Statements.
In addition, we read all the financial and non-financial information in the Annual Report to identify material inconsistencies with the audited Financial Statements and to identify any information that is apparently materially incorrect based on, or materially inconsistent with, the knowledge acquired by us in the course of performing the audit. If we become aware of any apparent material misstatements or inconsistencies we consider the implications for our report.
Andrew Partridge CA (Senior Statutory Auditor) for and on behalf of Deloitte LLP Chartered Accountants and Statutory Auditor Glasgow, United Kingdom
17 July 2015
For the Year Ended 31 March 2015
| Notes | Revenue £'000 |
Year ended 31 March 2015 Capital £'000 |
Total £'000 |
Revenue £'000 |
Year ended 31 March 2014 Capital £'000 |
Total £'000 |
|
|---|---|---|---|---|---|---|---|
| Gains on investments | 8 | - | 303 | 303 | - | 316 | 316 |
| Income from investments | 2 | 163 | - | 163 | 166 | - | 166 |
| Other income | 2 | - | - | - | 1 | - | 1 |
| Investment management fees | 3 | (31) | (122) | (153) | (32) | (129) | (161) |
| Other expenses | 4 | (139) | - | (139) | (128) | - | (128) |
| Net return on ordinary activities before taxation |
(7) | 181 | 174 | 7 | 187 | 194 | |
| Tax on ordinary activities | 5 | - | - | - | (1) | 1 | - |
| Return attributable to Equity Shareholders |
7 | (7) | 181 | 174 | 6 | 188 | 194 |
| Earnings per share (pence) | (0.1p) | 2.5p | 2.4p | 0.1p | 3.4p | 3.5p |
A Statement of Total Recognised Gains and Losses has not been prepared as all gains and losses are recognised in the Income Statement.
All items in the above statement are derived from continuing operations. The Company has only one class of business and derives its income from investments made in shares, securities and bank deposits.
The total column of this statement is the Profit and Loss Account of the Company.
For the Year Ended 31 March 2015
| Year ended 31 March 2015 £'000 |
Year ended 31 March 2014 £'000 |
||
|---|---|---|---|
| Opening Shareholders' funds | 3,617 | 2,874 | |
| Net return for year | 174 | 194 | |
| Net proceeds of share issue | 439 | 576 | |
| Dividend paid - Revenue | 12 | - | (27) |
| Dividend paid - Capital | 12 | (43) | - |
| Closing Shareholders' funds | 4,187 | 3,617 | |
The accompanying Notes are an integral part of the Financial Statements.
As at 31 March 2015
| Notes | 31 March 2015 £'000 |
31 March 2014 £'000 |
|
|---|---|---|---|
| Fixed assets | |||
| Investments at fair value through profit or loss | 8 | 3,365 | 3,136 |
| Current assets | |||
| Debtors | 9 | 67 | 77 |
| Cash | 15 | 793 | 488 |
| 860 | 565 | ||
| Creditors | |||
| Amounts falling due within one year | 10 | 38 | 84 |
| Net current assets | 822 | 481 | |
| Net assets | 4,187 | 3,617 | |
| Capital and reserves | |||
| Called up share capital | 11 | 3,617 | 3,204 |
| Share premium account | 12 | 53 | 27 |
| Capital reserve - realised | 12 | (1,327) | (1,396) |
| Capital reserve - unrealised | 12 | 381 | 312 |
| Special distributable reserve | 12 | 2,389 | 2,389 |
| Revenue reserve | 12 | (926) | (919) |
| Net assets attributable to Ordinary Shareholders | 4,187 | 3,617 | |
| Net asset value per Ordinary Share (pence) | 13 | 57.9 | 56.5 |
The Financial Statements of Maven Income and Growth VCT 6 PLC, registered number 3870187, were approved by the Board on 17 July 2015 and were signed on its behalf by:
The accompanying Notes are an integral part of the Financial Statements.
For the Year Ended 31 March 2015
| Year ended 31 March 2015 | Year ended 31 March 2014 | ||||
|---|---|---|---|---|---|
| Notes | £'000 | £'000 | £'000 | £'000 | |
| Operating activities | |||||
| Investment income received | 184 | 172 | |||
| Investment management fees paid | (100) | (100) | |||
| Performance fees paid | (104) | - | |||
| Other cash payments | (134) | (126) | |||
| Net cash outflow from operating activities | 14 | (154) | (54) | ||
| Financial investment | |||||
| Purchase of investments | (2,033) | (560) | |||
| Sale of investments | 2,096 | 493 | |||
| Net cash inflow/(outflow) | 63 | (67) | |||
| from financial investment | |||||
| Equity dividends paid | (43) | (27) | |||
| Net cash outflow before financing | (134) | (148) | |||
| Financing | |||||
| Issue of Ordinary Shares | 439 | 576 | |||
| Net cash inflow from financing | 439 | 576 | |||
| Increase in cash | 15 | 305 | 428 | ||
The accompanying Notes are an integral part of the Financial Statements.
For the Year Ended 31 March 2015
The Financial Statements have been prepared under the historical cost convention, modified to include the revaluation of investments, and in accordance with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the SORP) issued in January 2009. The disclosures on going concern in the Directors' Report form part of these Financial Statements.
Dividends receivable on equity shares and unit trusts are treated as revenue for the period on an ex-dividend basis. Where no ex-dividend date is available dividends receivable on or before the year end are treated as revenue for the period. Provision is made for any dividends not expected to be received. The fixed returns on debt securities and non-equity shares are recognised on a time apportionment basis so as to reflect the effective interest rate on the debt securities and shares. Provision is made for any fixed income not expected to be received. Interest receivable from cash and short term deposits and interest payable are accrued to the end of the year.
All expenses are accounted for on an accruals basis and charged to the Income Statement. Expenses are charged through the revenue account except as follows:
Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date, where transactions or events that result in an obligation to pay more tax in the future or right to pay less tax in the future have occurred at the balance sheet date. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the Company's taxable profits and its results as stated in the Financial Statements which are capable of reversal in one or more subsequent periods.
Deferred tax is measured on a non-discounted basis at the tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted or substantively enacted at the balance sheet date.
The tax effect of different items of income/gain and expenditure/loss is allocated between capital reserves and revenue account on the same basis as the particular item to which it relates using the Company's effective rate of tax for the period.
UK corporation tax is provided at amounts expected to be paid/recovered using the tax rates and laws that have been enacted or substantively enacted at the balance sheet date.
In valuing unlisted investments the Directors follow the criteria set out below. These procedures comply with the revised International Private Equity and Venture Capital Valuation Guidelines (IPEVCV) for the valuation of private equity and venture capital investments. Investments are recognised at their trade date and are designated by the Directors as fair value through profit or loss. At subsequent reporting dates, investments are valued at fair value, which represents the Directors' view of the amount for which an asset could be exchanged between knowledgeable and willing parties in an arm's length transaction. This does not assume that the underlying business is saleable at the reporting date or that its current shareholders have an intention to sell their holding in the near future.
A financial asset or liability is generally derecognised when the contract that gives rise to it is settled, sold, cancelled or expires.
Fair value is defined as the price that the Company would receive upon selling an investment in a timely transaction to an independent buyer in the principal or the most advantageous market of the investment. A three-tier hierarchy has been established to maximise the use of observable market data and minimise the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk, for example, the risk inherent in a particular valuation technique used to measure fair value including such a pricing model and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable.
Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity.
Unobservable inputs are inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on best information available in the circumstances
The three-tier hierarchy of inputs is summarised in the three broad levels listed below.
When the Company sells or revalues its investments during the year, any gains or losses arising are credited/charged to the Income Statement.
| 2. Income |
Year ended 31 March 2015 £'000 |
Year ended 31 March 2014 £'000 |
|---|---|---|
| Income from investments: | ||
| UK franked investment income | 2 | 2 |
| UK unfranked investment income | 161 | 164 |
| 163 | 166 | |
| Other income: | ||
| Deposit interest | - | 1 |
| Total income | 163 | 167 |
| 3. Investment Management Fees | Revenue £'000 |
Capital £'000 |
Year ended 31 March 2015 Total £'000 |
Revenue Capital £'000 |
£'000 | Year ended 31 March 2014 Total £'000 |
|---|---|---|---|---|---|---|
| Investment management fees | 20 | 80 | 100 | 20 | 80 | 100 |
| Performance fees | 11 | 42 | 53 | 12 | 49 | 61 |
| 31 | 122 | 153 | 32 | 129 | 161 | |
| 4. | Other Expenses | Revenue £'000 |
Capital £'000 |
Year ended 31 March 2015 Total £'000 |
Revenue Capital £'000 |
£'000 | Year ended 31 March 2014 Total £'000 |
|---|---|---|---|---|---|---|---|
| Secretarial fees | 36 | - | 36 | 36 | - | 36 | |
| Directors' remuneration | 17 | - | 17 | 17 | - | 17 | |
| Fees to Auditor - audit services | 11 | - | 11 | 10 | - | 10 | |
| Fees to Auditor - tax services | 3 | - | 3 | 3 | - | 3 | |
| Miscellaneous expenses | 72 | - | 72 | 62 | - | 62 | |
| 139 | - | 139 | 128 | - | 128 | ||
| 5. Tax on Ordinary Activities | Revenue £'000 |
Capital £'000 |
Year ended 31 March 2015 Total £'000 |
Revenue £'000 |
Capital £'000 |
Year ended 31 March 2014 Total £'000 |
|---|---|---|---|---|---|---|
| Corporation tax | - | - | - | (1) | 1 | - |
The tax charge for the year shown in the Income Statement is lower than the standard rate of corporation tax in the UK of 21% (2014: 23%). The differences are explained below:
| Revenue £'000 |
Capital £'000 |
Year ended 31 March 2015 Total £'000 |
Revenue £'000 |
31 March 2014 Capital £'000 |
Year ended Total £'000 |
|
|---|---|---|---|---|---|---|
| Return on ordinary activities before taxation | (7) | 181 | 174 | 7 | 187 | 194 |
| Revenue return on ordinary activities multiplied by standard rate of corporation tax |
(1) | 38 | 37 | 2 | 43 | 45 |
| Gains on investments | - | (64) | (64) | - | (73) | (73) |
| Smaller Companies Relief | (26) | 26 | - | (30) | 29 | (1) |
| Movement in excess management expenses | 27 | - | 27 | 29 | - | 29 |
| - | - | - | 1 | (1) | - | |
The Company has not recognised a deferred tax asset of £346,546 (2014: £349,000) arising as a result of having unutilised management expenses. It is unlikely that the Company will obtain relief for these in the future, so no deferred tax asset has been recognised.
| 6. Dividends We set out below the final dividends proposed in respect of the financial year, which reflect the requirements of Section 274 of the Income Tax Act 2007. |
Year ended 31 March 2015 £'000 |
Year ended 31 March 2014 £'000 |
|---|---|---|
| Revenue dividends | ||
| Revenue available for distribution by way of dividends for the year |
(7) | 6 |
| Final revenue dividend for the year ended 31 March 2015 of Nil (2014: Nil) |
- | - |
| Capital dividends | ||
| Final capital dividend for the year ended 31 March 2015 of 0.7p (2014: 0.6p) payable on 11 September 2015 |
51 | 38 |
| 7. Return per Ordinary Share | Year ended 31 March 2015 |
Year ended 31 March 2014 |
|---|---|---|
| The returns per share have been based on the following figures: |
||
| Weighted average number of Ordinary Shares |
7,164,064 | 5,477,652 |
| Revenue return | (£7,000) | £6,000 |
| Capital return | £181,000 | £188,000 |
| Total return | £174,000 | £194,000 |
Financial Statements
| Listed Unlisted (quoted (unobservable prices) inputs) £'000 £'000 |
AIM/ISDX (quoted prices) Total £'000 £'000 |
|||
|---|---|---|---|---|
| 15 | 3,066 | 55 | 3,136 | |
| (15) | (631) | 334 | (312) | |
| - | 2,435 | 389 | 2,824 | |
| 998 | 961 | 74 | 2,033 | |
| (1,008) | (1,086) | (13) | (2,107) | |
| 10 | 228 | (4) | 234 | |
| - | 2,538 | 446 | 2,984 | |
| 5 | 698 | (322) | 381 | |
| 5 | 3,236 | 124 | 3,365 | |
| Year ended 31 March 2015 |
Note 1(f) defines the three tier hierarchy of investments, and the significance of the information used to determine their fair value, that is required by Financial Reporting Standard (FRS) 29 "Financial Instruments: Disclosures". Listed and AIM/ISDX securities are categorised as Level 1 and unlisted securities as Level 3.
FRS 29 requires disclosure, by class of financial instrument, if the effect of changing one or more inputs to reasonably possible alternative assumptions would result in a significant change to the fair value measurement. The information used in determination of the fair value of Level 3 investments is chosen with reference to the specific underlying circumstances and the position of each investee company. The Directors are of the view that there are no reasonably possible alternative assumptions that will have a significant effect on the valuation of the unlisted portfolio.
| The portfolio valuation held at market valuation: |
31 March 2015 £'000 |
31 March 2014 £'000 |
|---|---|---|
| Listed investments | 5 | 15 |
| AIM/ISDX quoted equities | 124 | 55 |
| 129 | 70 | |
| Unlisted at Directors' valuation: | ||
| Unlisted unobservable equities | 1,575 | 1,417 |
| Unlisted unobservable fixed income | 1,661 | 1,649 |
| 3,236 | 3,066 | |
| Total | 3,365 | 3,136 |
| Realised gains on historical basis | 234 | 61 |
| Movement in net unrealised gains | 69 | 255 |
| Gains on investments | 303 | 316 |
| 9. Debtors | 31 March 2015 £'000 |
31 March 2014 £'000 |
|---|---|---|
| Prepayments and accrued income | 51 | 76 |
| Other debtors | 11 | - |
| Current tax | 5 | 1 |
| 67 | 77 | |
| 10.Creditors | 31 March 2015 £'000 |
31 March 2014 £'000 |
||
|---|---|---|---|---|
| Amounts falling due within one year: | ||||
| Accruals | 38 | 84 | ||
| 38 | 84 | |||
| 11. Share Capital | Number | 31 March 2015 £'000 |
Number | 31 March 2014 £'000 |
| At 31 March 2015, the authorised share capital comprised: allotted, issued and fully paid Ordinary Shares of 50p each |
||||
| Balance brought forward | 6,407,688 | 3,204 | 5,309,102 | 2,655 |
| Issued during the year | 825,164 | 413 | 1,098,586 | 549 |
| 7,232,852 | 3,617 | 6,407,688 | 3,204 |
During the year, the Company issued 825,164 Ordinary Shares pursuant to an Offer for Subscription at a Subscription Price of 54.82p per share.
| 12.Reserves | Share premium account £'000 |
Capital reserve realised £'000 |
Capital reserve unrealised £'000 |
Special distributable reserve £'000 |
Revenue reserve £'000 |
|---|---|---|---|---|---|
| At 31 March 2014 | 27 | (1,396) | 312 | 2,389 | (919) |
| Gain on sale of investments | - | 234 | - | - | - |
| Net increase in value of investments | - | - | 69 | - | - |
| Investment management fees | - | (122) | - | - | - |
| Dividends paid | - | (43) | - | - | - |
| Tax effect of capital items | - | - | - | - | - |
| Share issue | 26 | - | - | - | - |
| Net return on ordinary activities after taxation | - | - | - | - | (7) |
| At 31 March 2015 | 53 | (1,327) | 381 | 2,389 | (926) |
| 13. Net Asset Value per Share | Net asset value per |
31 March 2015 Net asset value share attributable |
Net asset value per share |
31 March 2014 Net asset value attributable |
|---|---|---|---|---|
| p | £'000 | p | £'000 | |
| Ordinary Shares | 57.9 | 4,187 | 56.5 | 3,617 |
The number of Ordinary Shares used in this calculation is set out in Note 11.
| 14. Reconciliation of Net Return Before Taxation to Net Cash Outflow from Operating Activities |
Year ended 31 March 2015 £'000 |
Year ended 31 March 2014 £'000 |
|---|---|---|
| Net return on ordinary activities before taxation | 174 | 194 |
| Gains on investments | (303) | (316) |
| Decrease in accrued income | 25 | 5 |
| Increase in tax debtor | (4) | - |
| (Decrease)/increase in accruals | (46) | 63 |
| Net cash outflow from operating activities | (154) | (54) |
| 15. Analysis of Changes in Net Funds | 31 March | Cash | 31 March |
|---|---|---|---|
| 2014 | flows | 2015 | |
| £'000 | £'000 | £'000 | |
| Cash | 488 | 305 | 793 |
| 31 March | Cash | 31 March | |
| 2013 | flows | 2014 | |
| £'000 | £'000 | £'000 | |
| Cash | 60 | 428 | 488 |
The Company's financial instruments comprise equity and fixed interest investments, financial commitments and guarantees, cash balances and debtors and creditors that arise directly from its operations, for example, in respect of sales and purchases awaiting settlement, and debtors for accrued income. The Company holds financial assets in accordance with its investment policy of investing mainly in a portfolio of VCT qualifying unquoted and AIM/ISDX quoted securities. The Company may not enter into derivative transactions in the form of forward foreign currency contracts, futures and options without the written approval of the Directors. It is not the Company's policy to enter into derivative transactions.
The main risks the Company faces from its financial instruments are: (i) market price risk, being the risk that the value of investment holdings will fluctuate as a result of changes in market prices caused by factors other than interest rate or currency movement; (ii) interest rate risk; (iii) liquidity risk; (iv) credit risk; and (v) price risk sensitivity. In line with the Company's investment objective, the portfolio comprises UK securities and, therefore, has no exposure to foreign currency risk.
The Manager's policies for managing these risks are summarised below and have been applied throughout the year. The numerical disclosures below exclude short-term debtors and creditors which are included in the Balance Sheet at fair value.
The Company's investment portfolio is exposed to market price fluctuations, which are monitored by the Manager in pursuance of the investment objective. Adherence to investment guidelines and to investment borrowing powers set out in the Management and Administration Deed mitigates the risk of excessive exposure to any particular type of security or issuer and, in particular, no purchase can be made in any one company where this would result in a holding that would exceed 15% of the Company's investments.
These powers and guidelines include the requirement to invest in a number of companies across a range of industrial and service sectors at varying stages of development but with no emphasis on well established businesses. The Company complied with the stated investment guidelines and borrowing powers throughout the year ended 31 March 2015.
Further information on the investment portfolio (including sector analysis, concentration and deal type analysis) is set out in the Analysis of Unlisted and Quoted Portfolio, Investment Manager's Review, Summary of Portfolio Performance, Investment Portfolio Summary and Largest Investments by Valuation.
The interest rate risk profile of financial assets at the balance sheet date was as follows:
| Sterling | Fixed interest |
Floating rate £'000 |
Non-interest bearing £'000 |
|---|---|---|---|
| Unlisted | 1,661 | - | 1,575 |
| AIM/ISDX | - | - | 129 |
| Cash | - | 793 | - |
| 1,661 | 793 | 1,704 |
| 31 March 2014 | ||||||
|---|---|---|---|---|---|---|
| Sterling | Fixed interest £'000 |
Floating rate £'000 |
Non-interest bearing £'000 |
|||
| Unlisted | 1,649 | - | 1,417 | |||
| AIM/ISDX | - | - | 70 | |||
| Cash | - | 488 | - | |||
| 1,649 | 488 | 1,487 |
The unlisted fixed interest assets have a weighted average life of 2.6 years (2014: 2.4 years) and a weighted average interest rate of 9.8% (2014: 10.0%).
It is the Directors' opinion that the carrying amounts of these financial assets represent the maximum credit risk exposure at the balance sheet date.
67
The maturity profile of the Company's financial assets at the balance sheet date was as follows:
| At 31 March 2015 | Within 2 years £'000 |
Within 2-3 years £'000 |
Within 3-4 years £'000 |
Within 4-5 years £'000 |
More than 5 years £'000 |
Total £'000 |
|---|---|---|---|---|---|---|
| Unlisted | 508 | 282 | 468 | 145 | 258 | 1,661 |
| 508 | 282 | 468 | 145 | 258 | 1,661 |
Within "more than 5 years" there is a figure of £842 (2014: £878), in respect of preference shares which have no redemption date.
| At 31 March 2014 | Within 2 years £'000 |
Within 2-3 years £'000 |
Within 3-4 years £'000 |
Within 4-5 years £'000 |
More than 5 years £'000 |
Total £'000 |
|---|---|---|---|---|---|---|
| Unlisted | 716 | 58 | 304 | 563 | 8 | 1,649 |
| 716 | 58 | 304 | 563 | 8 | 1,649 |
Due to their nature, unlisted investments may not be readily realisable and therefore a portfolio of listed assets and cash is held to offset this liquidity risk. Note 1(f) details the three-tier hierarchy of inputs used as at 31 March 2015 in valuing the Company's investments carried at fair value.
The Company, generally, does not hold significant cash balances and any cash held is at reputable banks with high quality external credit ratings.
This is the risk that a counterparty to a financial instrument will fail to discharge an obligation or commitment that it has entered into with the Company.
The Company's financial assets exposed to credit risk amounted to the following:
| 31 March 2015 £'000 |
31 March 2014 £'000 |
|
|---|---|---|
| Investments in unlisted debt securities | 1,661 | 1,649 |
| Cash | 793 | 488 |
| 2,454 | 2,137 |
All fixed interest assets which are traded on a recognised exchange are held by JP Morgan Chase (JPM), the Company's custodian. Cash balances are held by JPM and RBS. Should the credit quality or the financial position of any of these institutions deteriorate significantly the Manager will move these assets to another provider.
The Manager evaluates credit risk on unlisted debt securities and financial commitments and guarantees prior to investment, and as part of the ongoing monitoring of investments. In doing this, it takes into account the extent and quality of any security held.
Typically, unlisted debt securities have a fixed charge over the assets of the investee company in order to mitigate the gross credit risk. The Manager receives management accounts from investee companies and members of the investment management team sit on the boards of investee companies; this enables the close identification, monitoring and management of investment specific credit risk.
There were no significant concentrations of credit risk to counterparties at 31 March 2015 or 31 March 2014.
The following details the Company's sensitivity to a 10% increase and decrease in the market prices of AIM/ISDX quoted securities, with 10% being the Manager's assessment of a reasonable possible change in market prices.
At 31 March 2015, if market prices of AIM/ISDX quoted securities had been 10% higher or lower with all other variables held constant, the increase or decrease in net assets attributable to Ordinary Shareholders for the year would have been £12,900 (2014: £7,000), due to the change in valuation of financial assets at fair value through profit or loss.
At 31 March 2015, 96.2% (2014: 97.8%) comprised investments in unquoted companies held at fair value. The valuation of unquoted investments reflects a number of factors, including the performance of the investee company itself and the wider market. Therefore, it is not considered meaningful to provide a sensitivity analysis on the net asset position and total return for the year due to the fact any such movements would be immaterial to users of Financial Statements.
69
Notice is hereby given that the Annual General Meeting of Maven Income and Growth VCT 6 PLC (the Company; Registered in England and Wales with registered number 3870187) will be held at 11.00 am on Thursday 3 September 2015 at 5th Floor 1-2 Royal Exchange Buildings, London EC3V 3LF, for the purposes of considering and, if thought fit, passing the following Resolutions:
a) the maximum number of Ordinary Shares hereby authorised to be purchased is 1,084,204;
b) the minimum price, exclusive of expenses, that may be paid for an Ordinary Share shall be 10p per share;
By order of the Board Maven Capital Partners UK LLP Secretary Fifth Floor 1-2 Royal Exchange Buildings London EC3V 3LF
17 July 2015
1) To be entitled to attend and vote at the Meeting (and for the purposes of the determination by the Company of the votes that may be cast in accordance with Regulation 41 of the Uncertified Securities Regulations 2001), only those members registered in the Company's register of members at 11.00 am on 1 September 2015 (or, if the Meeting is adjourned, 5.00 pm on the date which is two business days before the adjourned Meeting) shall be entitled to attend and vote at the Meeting. Changes to the register of members of the Company after the relevant deadline shall be disregarded in determining the rights of any person to attend and vote at the Meeting.
2) Information regarding the Meeting, including the information required by Section 311A of the Companies Act 2006, is available from www.mavencp.com/migvct6.
3) If you wish to attend the Meeting in person, please bring some form of identification.
8) A vote withheld is not a vote in law, which means that the vote will not be counted in the calculation of votes for or against the resolution. If no voting indication is given, your proxy will vote or abstain from voting at his or her discretion. Your proxy will vote (or abstain from voting) as he or she thinks fit in relation to any other matter which is put before the Meeting.
9) A form of proxy is enclosed with this document. The notes to the proxy form explain how to direct your proxy to vote or withhold their vote on each Resolution. To appoint a proxy using the proxy form, the form must be completed, signed and sent or delivered to the Company's registrars, Capita Asset Services, at The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU so as to be received by Capita Asset Services no later than 11.00 am on 1 September 2015 or by 5.00 pm on a date two business days prior to that appointed for any adjourned Meeting or, in the case of a poll taken subsequent to the date of the Meeting or adjourned Meeting, so as to be received no later than 24 hours before the time appointed for taking the poll. In the case of a member which is a company, the proxy form must be executed under its common seal or signed on its behalf by an officer of the company or an attorney for the company. Any power of attorney or any other authority under which the proxy form is signed (or a duly certified copy of such power or authority) must be included with the proxy form. For the purposes of determining the time for delivery of proxies, no account has been taken of any part of a day that is not a working day.
10) CREST members who wish to appoint a proxy or proxies by utilising the CREST electronic proxy appointment service may do so for the Meeting and any adjournment(s) of it by using the procedures described in the CREST Manual (available from https://www.euroclear.com/site/public/EUI). CREST Personal Members or other CREST sponsored members, and those CREST members who have appointed a voting service provider(s), should refer to their CREST sponsor or voting service provider(s), who will be able to take the appropriate action on their behalf. In order for a proxy appointment made by means of CREST to be valid, the appropriate CREST message (a CREST Proxy Instruction) must be properly authenticated in accordance with Euroclear UK & Ireland Limited's (EUI) specifications and must contain the information required for such instructions, as described in the CREST Manual. The message must be transmitted so as to be received by the issuer's agent (ID: RA10) by 11.00 am on 1 September 2015. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Applications Host) from which the issuer's agent is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST.
CREST members and, where applicable, their CREST sponsors or voting service providers should note that EUI does not make available special procedures in CREST for any particular messages. Normal system timings and limitations will therefore apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member or sponsored member or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time.
In this connection, CREST members and, where applicable, their CREST sponsors or voting service providers are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5) (a) of the Uncertificated Securities Regulations 2001.
11) In the case of joint holders, where more than one of the joint holders purports to appoint a proxy, only the appointment submitted by the most senior holder will be accepted. Seniority is determined by the order in which the names of the joint holders appear in the Company's register of members in respect of the joint holding, the first-named being the most senior.
12) To change your proxy instructions simply submit a new proxy appointment using the methods set out above. Note that the cut-off times for receipt of proxy appointments (see above) also apply in relation to amended instructions; any amended proxy appointment received after the relevant cut-off time will be disregarded. Where you have appointed a proxy using the hard-copy proxy form and would like to change the instructions using another hard-copy proxy form, please contact Capita Asset Services at the address shown in note 9. If you submit more than one valid proxy appointment, the appointment received last before the latest time for the receipt of proxies will take precedence.
13) In order to revoke a proxy instruction you will need to inform the Company by sending a signed hard copy notice clearly stating your intention to revoke your proxy appointment to Capita Asset Services, at the address shown in note 9. In the case of a member which is a company, the revocation notice must be executed under its common seal or signed on its behalf by an officer of the company or an attorney for the company. Any power of attorney or any other authority under which the revocation notice is signed, or a duly certified copy of such power or authority, must be included with the revocation notice. The revocation notice must be received by Capita Asset Services no later than 48 hours before the Meeting. If you attempt to revoke your proxy appointment but the revocation is received after the time specified then, subject to the paragraph directly below, your proxy appointment will remain valid. Appointment of a proxy does not preclude you from attending the Meeting and voting in person. If you have appointed a proxy and attend the Meeting in person, your proxy appointment will automatically be terminated.
14) A corporation which is a member can appoint one or more corporate representatives who may exercise, on its behalf, all its powers as a member provided that no more than one corporate representative exercises powers over the same share.
15) As at 10 July 2015, the Company's issued share capital comprised 7,232,852 Ordinary shares of 50p each. Each Ordinary Share carries the right to one vote at a General Meeting of the Company and, therefore, the total number of voting rights in the Company on 10 July 2015 is 7,232,852. The website referred to in note 2 will include information on the number of shares and voting rights.
18) In order to be able to exercise the members' rights under notes 17, 23 and/or 24, the relevant request must be made by a member or members having a right to vote at the Meeting and holding at least 5% of total voting rights of the Company, or at least 100 members having a right to vote at the Meeting and holding, on average, at least £100 of paid up share capital. For information on voting rights, including the total number of voting rights, see note 15 above and the website referred to in note 2.
21) Copies of the letters of appointment of the Directors of the Company and a copy of the Articles of Association of the Company will be available for inspection at the registered office of the Company and at Kintyre House, 205 West George Street, Glasgow G2 2LW from the date of this notice until the end of the Meeting.
An explanation of the Resolutions to be proposed at the Annual General Meeting is set out below. Resolutions 1 to 10 will be proposed as Ordinary Resolutions requiring the approval of more than 50% of the votes cast and Resolutions 11 to 13 will be proposed as Special Resolutions requiring the approval of 75% or more of the votes cast.
The Directors seek approval to receive the Directors' Report and audited Financial Statements for the year ended 31 March 2015 which are included within the Annual Report.
The Board seeks the approval of the Directors' Remuneration Report for the year ended 31 March 2015, which is also included within the Annual Report.
The Company's Shareholders will be asked to approve a final dividend of 0.7p per Ordinary Share for the year ended 31 March 2015 for payment on 11 September 2015 to Shareholders on the register at the close of business on 14 August 2015.
Jonathan Carr retires annually in accordance with corporate governance best practice and, being eligible, is offering himself for re-election.
Brian May retires annually in accordance with corporate governance best practice and, being eligible, is offering himself for re-election.
Gregor Logan will retire at the Annual General Meeting, being the first following his appointment and, being eligible, is offering himself for re-election.
Bill Nixon, as a non-independent Director, retires annually in accordance with corporate governance best practice and, being eligible, is offering himself for re-election.
Shareholders will be asked to approve the re-appointment of Deloitte LLP as the Company's Auditor; Deloitte LLP having expressed their willingness to remain in office.
Shareholders will be asked to give the Directors' authority to fix the remuneration of Deloitte LLP.
The Directors are seeking authority pursuant to Section 551 of the Act for the Company to allot Ordinary Shares or rights to subscribe for Ordinary Shares up to an aggregate nominal value of £361,642. This amounts to 723,284 Ordinary Shares representing approximately 10% of the issued share capital as at 10 July 2015 (this being the latest practicable date prior to the publication of this Annual Report). This authority will be used for the purposes set out in Resolution 10.
The authority conferred by Resolution 10 will expire at the conclusion of the next Annual General Meeting of the Company or on the expiry of 15 months from the passing of the Resolution, whichever is the first to occur.
Shareholders will be asked to grant authority to the Directors to allot Ordinary Shares (i) on a pre-emptive basis to existing Shareholders as far as possible, subject to excluding circumstances where it is impractical to apply the strict pro-rating; and (ii) otherwise allot Ordinary Shares or rights to subscribe for Ordinary Shares up to an aggregate nominal value of £361,642 (representing, in accordance with institutional investor guidelines, approximately 10% of the issued share capital as at 10 July 2015, this being the latest practicable date prior to the publication of this Annual Report) as if the pre-emption rights of Section 561 of the Act did not apply, in each case where the proceeds may be used in whole or part to purchase existing Ordinary Shares. The authority conferred by Resolution 11 will expire at the conclusion of the next Annual General Meeting of the Company or on the expiry of 15 months from the passing of the Resolution, whichever is the first to occur. The Board may use the authorities conferred under Resolutions 10 and 11 to allot further Ordinary Shares or rights to subscribe for them.
Shareholders will be asked to authorise the Company to make market purchases of up to 1,084,204 Ordinary Shares (representing approximately 14.99% of the issued share capital as at 10 July 2015, this being the latest practicable date prior to the publication of this Annual Report). The Resolution sets out the minimum and maximum prices that can be paid, exclusive of expenses, and Ordinary Shares bought back may be cancelled or held in treasury as may be determined by the Board. The authority conferred by Resolution 12 will expire at the conclusion of the next Annual General Meeting of the Company or on the expiry of 15 months from the passing of the Resolution, whichever is the first to occur. Once held in treasury, such Ordinary Shares may be sold for cash or cancelled. The Board may use this authority to allow the Company to operate a share buy-back policy.
The Directors propose to preserve the Company's ability to call general meetings (other than annual general meetings) on 14 clear days' notice, as previously approved by Shareholders at the last Annual General Meeting. Resolution 13 seeks such approval and would be effective until the Company's next Annual General Meeting when it would be intended that a similar Resolution be proposed. It is anticipated that, if confirmed, such authority will only be used in exceptional circumstances. The Company will also need to meet the requirements for electronic voting before it can call a general meeting on 14 days' notice.
Annual General Meeting
| Directors | Jonathan Carr (Chairman) | |
|---|---|---|
| Stephen Barclay | ||
| Brian May | ||
| Gregor Logan | ||
| Bill Nixon | ||
| Manager and Secretary | Maven Capital Partners UK LLP | |
| Kintyre House | ||
| 205 West George Street | ||
| Glasgow G2 2LW | ||
| Telephone: 0141 306 7400 | ||
| E-mail: [email protected] | ||
| Registered Office | Fifth Floor | |
| 1-2 Royal Exchange Buildings | ||
| London | ||
| EC3V 3LF | ||
| Registered in England and Wales | Company Registration Number: 3870187 | |
| Website | www.mavencp.com/migvct6 | |
| Registrars | Capita Asset Services | |
| The Registry | ||
| 34 Beckenham Road | ||
| Beckenham | ||
| Kent BR3 4TU | ||
| Website: www.capitaassetservices.com | ||
| Shareholder Portal: www.capitashareportal.com | ||
| Shareholder Helpline: 0333 300 1566 | ||
| (Lines are open 9 am until 5.30 pm, Monday to Friday excluding | ||
| public holidays in England and Wales. Calls are charged at the | ||
| standard geographic rate and will vary by provider. Calls from outside | ||
| the United Kingdom should be made to +44 208 639 3399 and will | ||
| be charged at the applicable international rate.) | ||
| Auditor | Deloitte LLP | |
| Bankers | J P Morgan Chase Bank | |
| Stockbrokers | Shore Capital Stockbrokers Limited | |
| Telephone: 020 7647 8132 | ||
Maven Capital Partners UK LLP Kintyre House 205 West George Street Glasgow G2 2LW
Tel 0141 306 7400
Authorised and Regulated by The Financial Conduct Authority
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.